WO2008137637A2 - Methods, arrangements and systems for obtaining information associated with a sample using brillouin microscopy - Google Patents

Methods, arrangements and systems for obtaining information associated with a sample using brillouin microscopy Download PDF

Info

Publication number
WO2008137637A2
WO2008137637A2 PCT/US2008/062354 US2008062354W WO2008137637A2 WO 2008137637 A2 WO2008137637 A2 WO 2008137637A2 US 2008062354 W US2008062354 W US 2008062354W WO 2008137637 A2 WO2008137637 A2 WO 2008137637A2
Authority
WO
WIPO (PCT)
Prior art keywords
sample
electro
frequency
paragraph
magnetic radiation
Prior art date
Application number
PCT/US2008/062354
Other languages
French (fr)
Other versions
WO2008137637A3 (en
Inventor
Seok-Hyun Yun
Giuliano Scarcelli
Original Assignee
The General Hospital Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The General Hospital Corporation filed Critical The General Hospital Corporation
Publication of WO2008137637A2 publication Critical patent/WO2008137637A2/en
Publication of WO2008137637A3 publication Critical patent/WO2008137637A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01JMEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/28Investigating the spectrum
    • G01J3/44Raman spectrometry; Scattering spectrometry ; Fluorescence spectrometry
    • G01J3/4412Scattering spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01JMEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/12Generating the spectrum; Monochromators
    • G01J3/26Generating the spectrum; Monochromators using multiple reflection, e.g. Fabry-Perot interferometer, variable interference filters

Definitions

  • the present invention relates to methods, arrangements and systems which can obtain acoustic information associated with a sample using electromagnetic radiation, and more particularly to such methods, systems and arrangements that can obtain viscoelastic properties of the sample by performing highly efficient Brillouin optical spectroscopy and imaging.
  • This invention further relates to methods, arrangements and systems that combine Brillouin spectroscopy or imaging with reflectance, fluorescence, or Raman spectroscopy or imaging for simultaneous multimodal characterization of a sample.
  • Brillouin scattering involves acoustic phonons, which may be different from Raman scattering that involves vibrational or rotational phonons.
  • Spontaneous Brillouin scattering involves acoustic phonons that may be present in a material by thermally-induced density fluctuations. Brillouin scattering can be further enhanced, stimulated, or forced by one or multiple optical pump waves with strong intensity.
  • the magnitude and frequency of Brillouin-scattered light, or its optical spectrum can be determined by characteristics of the acoustic phonons inside the material. The latter may be closely related to mechanical properties of the medium, such as modulus and hypersonic damping coefficient. Such viscoelastic properties therefore may be measurable by examining the Brillouin scattered light. This technique is referred to as Brillouin spectroscopy.
  • Various techniques to detect the Brillouin signal have been widely applied in physics, material science, and mechanical engineering.
  • exemplary embodiments of imaging systems, arrangements and processes can be provided that are capable of combining a rapid spectroscopic analysis of Brillouin scattering with high spatial-resolution microscopy to probe a sample such as human tissue or artificially engineered tissue or other natural and synthetic biomaterial and retrieve their biomechanical properties such as complex modulus at the tissue.
  • a novel rapid yet high-resolution spectroscopic analysis can enable the image formation.
  • a pump beam can be scanned over a sample through an objective lens, and Brillouin-shifted optical waves are detected to characterize their Brillouin spectra.
  • the measured spectral features of the Brillouin signal can be used as contrast for imaging; an image can be obtained by use of a proper lookup table or an appropriate processing computational routine.
  • Thin cross-sectional images of a biological sample can be obtained by using a high numerical-aperture objective lens and confocal detection.
  • the rapid spectral analysis can be multiplexed for different regimes.
  • This can include empowering an optical microscope with different spectral modalities.
  • Elastic scattering, Raman scattering, and/or fluorescence as well as Brillouin scattering from a sample can be simultaneously measured and three-dimensionally mapped to obtain a structural, chemical, functional as well as mechanical information of the sample.
  • Exemplary embodiments of the present invention provide apparatus and methods which can allow information about biomechanical properties of a material, particularly a biomaterial, to be obtained non-invasively. Such exemplary embodiments can find a wide range of applications in biology and medicine as well as tissue engineering. Potential applications of Brillouin microscopy include in situ, or in vivo, real-time characterization of collagen cross-linking, intraoperative characterizations of tissues based on biomechanical properties, in vivo disease diagnosis, intraoperative tumor margin determination, wound healing monitoring and/or tissue ablation monitoring. [0011] For example, using the exemplary embodiments of the present invention, it is possible to obtain the viscoelastic properties of a sample such as biomaterial, by performing highly efficient Brillouin optical spectroscopy or imaging. Further exemplary embodiments of the present invention can further relate to methods, arrangements and systems that combine Brillouin spectroscopy and imaging with reflectance, fluorescence, or Raman spectroscopy and imaging for simultaneous multimodal characterization of a sample.
  • arrangements and methods are provided for obtaining information about a sample.
  • a first arrangement it is possible (e.g., using a first arrangement) to receive a first electro-magnetic radiation from a sample which is based on a second electromagnetic radiation forwarded to the sample.
  • the first electro-magnetic radiation can have a first frequency and the second electro-magnetic radiation has a second frequency which is different from the first frequency.
  • the difference between the first and second frequencies can be based on an acoustic wave inside the sample related to at least one characteristic of the sample.
  • such difference can be is between about -100 GHz and +100 GHz and may be based on an acoustic wave inside the sample related to at least one characteristic of the sample.
  • the first arrangement may employ a confocal pinhole or single-mode optical fiber.
  • N can correspond to the number of spectrally resolvable elements and, typically, can range from about 10 to 100 for a Fabry-Perot interferometer or a diffractive grating.
  • a plurality of such frequency component radiations can be simultaneously measured by an array of detectors, where the total combined energy of the frequency component radiations may be greater than 1/N times the energy of the received portion of the first electromagnetic radiation.
  • the information may be related to a difference between the first and second frequencies, an optical energy associated with a particular finite group of frequency component radiations, and/or a linewidth of a plurality of the frequency component radiations, each of which may be associated with a particular frequency.
  • This linewidth can be equivalent to a linewidth of Brillouin scattering, which may be related to an acoustic damping coefficient of the sample.
  • a linewidth of each frequency component radiation can be equivalent to an intrinsic spectral resolution of the second arrangement such as, e.g., a spectrometer.
  • the retrieved information can relate to bio-mechanical properties of the sample that include but are not limited to a complex modulus of the sample, a cross linking of collagen or another anatomical structure.
  • the first arrangement can include a narrow-band spectral filter arrangement which can receive the first electro- magnetic radiation and attenuate at least a portion thereof which has a frequency which is approximately the same as the second frequency.
  • Still further exemplary embodiments of the present invention can provide (e.g., using another first arrangement) for a receipt of a first electro-magnetic radiation and a second electro-magnetic radiation provided from a sample, where the first and second electromagnetic radiations may be based on a third electro-magnetic radiation forwarded to the sample.
  • the first electro-magnetic radiation can have a first frequency
  • the second electro-magnetic radiation can have a second frequency
  • the third electro-magnetic radiation can have a third frequency which may be different from the first frequency.
  • a difference between the first and third frequencies can be based on an acoustic wave inside the sample which may be related to at least one characteristic of the sample.
  • the second electromagnetic radiation can be based on at least one of an elastic scattering, a Raman scattering or a fluorescence within the sample.
  • first and second electro-magnetic radiations are separated into first and second frequency component radiations, respectively.
  • a narrow band spectral separating arrangement can be provided to separate the first electro-magnetic radiation, and a broadband spectral separating arrangement configured to separate the second electro-magnetic radiation.
  • FIG. 1 is a schematic illustration of an exemplary Brillouin effect
  • FIG. 2 is a block diagram of an exemplary apparatus which includes a scanning-beam Brillouin spectroscopy arrangement in accordance with certain exemplary embodiments of the present invention
  • FIG. 3A is a first schematic illustration of an exemplary embodiment of a exemplary beam focusing procedure
  • FIG. 3B is a second schematic illustration of an exemplary embodiment of a beam focusing procedure
  • Fig. 3C is a third schematic illustration of an exemplary embodiment of a beam focusing procedure
  • FIG. 4 is a schematic illustration of a parallel detection spectrometer arrangement in accordance with exemplary embodiments of the present invention.
  • FIG. 5 is a schematic illustration of a tandem parallel detection spectrometer arrangement in accordance with exemplary embodiments of the present invention
  • Fig. 6 is a schematic illustration of a narrowband spectral filter arrangement in accordance with exemplary embodiments of the present invention
  • Fig. 7 is an exemplary graph of intensities of collected light in accordance with exemplary embodiments of the present invention.
  • FIG. 8 is a schematic illustration of an exemplary scanning-beam multi-modal spectroscopy - microscopy apparatus in accordance with exemplary embodiments of the present invention.
  • FIG. 9 is a schematic illustration of a prototype system in accordance with exemplary embodiments of the present invention.
  • Fig. 1OA is an illustration of an exemplary CCD pixel index in accordance with exemplary embodiments of the present invention.
  • Fig. 1OB is an exemplary analysis of spectral measurement of the index shown in Fig. 1OA;
  • FIG. 1OC is an illustration of an expanded view of a portion of the exemplary analysis of spectral measurement shown in Fig. 1 OB;
  • FIG. 11 is a further exemplary analysis of a spectral measurement in accordance with exemplary embodiments of the present invention.
  • Fig. 12 is an exemplary graph showing stability of a spectral analysis
  • Fig. 13 is an exemplary graph showing a dynamic monitoring of a Brillouin shift in accordance with exemplary embodiments of the present invention
  • Fig. 14 A is an illustration of a biomaterial sample which was imaged in accordance with exemplary embodiments of the present invention
  • Fig 14B is a first image obtained from the biomaterial sample shown in Fig. 14A in accordance with exemplary embodiments of the present invention.
  • Fig 14C is a second image obtained from the biomaterial sample shown in Fig. 14A in accordance with exemplary embodiments of the present invention.
  • FIG. 15A is an illustration of an exemplary Brillouin spectrum collected with a single- VIPA spectrometer in accordance with exemplary embodiments of the present invention
  • FIG. 15B is an illustration of an exemplary Brillouin spectrum collected with a tandem VIPA spectrometer in accordance with exemplary embodiments of the present invention
  • FIG. 16A is an illustration of the anatomy of a murine eyeball which was imaged in accordance with exemplary embodiments of the present invention.
  • Fig. 16B is a first exemplary measurement showing the depth profile of elasticity of a mouse eyeball measured in vivo in accordance with exemplary embodiments of the present invention
  • Fig. 16C is a second exemplary measurement showing the depth profile of elasticity of a mouse eyeball measured in vivo in accordance with exemplary embodiments of the present invention.
  • Fig. 17 is an illustration of exemplary collagen samples and their corresponding Brillouin signatures determined in accordance with exemplary embodiments of the present invention.
  • Fig. 18 is an exemplary measurement of different Brillouin signatures for different concentration of collagen samples and different degrees of collagen cross-linking determined in accordance with exemplary embodiments of the present invention.
  • Fig. 1 illustrates the principle of Brillouin scattering which may be used in exemplary embodiments of the present invention.
  • monochromatic pump light 11 with a frequency v p - ⁇ p 12 ⁇ or wavelength ⁇ p - c l v p can be provided incident on a medium 13 to be tested, hi a spontaneous version of the process, the acoustic waves, due to thermally- induced density fluctuations inside the medium, can generate a periodic refractive index variation 15.
  • the analyzed sample can be considered as being optically equivalent to a grating which is traveling at the velocity of sound.
  • the scattered light 17 has a different direction because of Bragg-diffraction, and may be Doppler-shifted in frequency by an acoustic wavelength. It can have a spectral linewidth which may be determined by the inverse of the lifetime of the measured acoustic phonon. Both Stokes and anti-Stokes components, of lower and higher frequencies respectively, can be equally generated in the spontaneous process. [0052]
  • the phase matching conditions between the pump and scattering light and the acoustic wave can be expressed as:
  • ⁇ and k are angular frequency and wave number, respectively, and the subscript A, p, and s represent the acoustic phonons, pump and scattering (or signal) photons, respectively.
  • the frequency of the phase matched phonons e.g., a difference between the pump and scattering photons, can be expressed as:
  • n is a refractive index of the sampled material
  • V is a sound velocity inside the medium
  • is an angle between incident and scattered optical radiation.
  • the linewidth of Brillouin radiation can be expressed as:
  • a represents an attenuation coefficient of the sound wave inside the sample.
  • the magnitude of the scattered radiation can provide additional information related to the coupling of acoustic and optical energy inside the sample and can be determined by the scattering cross section R B , as described in H. Z. Cummins and R. W. Gammon, "Rayleigh and Brillouin Scattering in Liquids - Landau-Placzek Ratio," Journal of Chemical Physics, vol. 44, pp. 2785-&, 1966.:
  • V m ⁇ is the interaction volume inside the sample
  • k is the Boltzmann constant
  • T is the f ⁇ ⁇ 2 temperature
  • p is the density of the material
  • p — can represent an electrostriction
  • the Brillouin phenomenon may be accelerated because of the presence of the scattered light.
  • the scattered light coherent with the pump light, can amplify the resonant acoustic wave which in turn enhances the Brillouin scattering.
  • This positive feedback can result in strong Brillouin shifted scattered light, a process which may be referred to as stimulated Brillouin scattering.
  • a Stokes Brillouin component e.g., having a frequency down shifted
  • the process can also be enhanced or forced when two monochromatic pump waves with frequencies separated by v A are incident on a sample, as described in T. Sonehara and H.
  • Brillouin interaction is typically a bulk phenomenon measuring bulk acoustic modes.
  • boundary effects can become significant in Brillouin scattering.
  • Confined acoustic modes can be preferentially enhanced depending on the geometrical properties of analyzed environments such as size and shape of boundaries or of their individual constituents.
  • An example of this effect is Brillouin scattering from thin films where optical radiation can be dominantly scattered by a surface acoustic wave that determines a dynamical deformation of the sample border known as surface-ripple, as described in R. Loudon, "Theory of Surface-Ripple Brillouin-Scattering by Solids," Physical Review Letters, vol.
  • Brillouin spectroscopy is a technique that can measure a spectrum of Brillouin scattered light with respect to the pump waves, thereby probing the characteristics of acoustic phonons in a medium. Under certain conditions, it can serve as a mechanical fingerprint of the medium.
  • Brillouin scattering can monitor the stress response of a sample to a one-dimensional sinusoidal strain of high frequency (GHz).
  • GHz sinusoidal strain of high frequency
  • the acoustic parameters directly measured (V and a) can be related to the longitudinal modulus through the density p of the material [3], e.g. :
  • a two-dimensional or three- dimensional microscopic mapping of the mechanical properties of a material, in particular a biological sample can be constructed by using rapidly acquired Brillouin spectroscopic signatures as contrast.
  • a pump or probe beam may be scanned laterally across the sample and spectral patterns from each region are recorded to create an image.
  • Light can be scanned with various conventional scanners including, e.g., galvanometer-mounted mirrors, polygonal mirror scanners and/or MEMS mirrors.
  • Another exemplary embodiment of the present invention can use a scanning mechanism located on a fiber-optic catheter or endoscope for an application to, for example, luminal organ imaging.
  • three independent parameters can be extracted by each collected spectrum and can serve as contrast mechanisms for imaging: Brillouin frequency shift (Eq. 3), Brillouin linewidth (Eq. 4), and Brillouin intensity (Eq. 5). All of these three properties can have peculiar signatures (e.g., elasticity, viscosity and electrostriction, respectively) of the sampled material.
  • Eq. 3 Brillouin frequency shift
  • Eq. 4 Brillouin linewidth
  • Eq. 5 Brillouin intensity
  • All of these three properties can have peculiar signatures (e.g., elasticity, viscosity and electrostriction, respectively) of the sampled material.
  • three separate images can be obtained, for example, using a false color lookup table, featuring such properties.
  • the three pieces of information can be used simultaneously for higher accuracy, especially at the interfaces between two different materials. For example, at the borders of the objects, a non-trivial imaging processing procedure can be applied rather than a simple false-color lookup table.
  • Brillouin lines of both materials can be measured, proportionally to the amount of incident light that excites each particular material. Therefore, rather than relying on only one of the spectral signatures, the various Brillouin lines can be discriminated, and their total strength can be accurately quantified and compared to the strength that would be observed away from an interface.
  • Fig. 2 depicts a block diagram of an exemplary apparatus in accordance with exemplary embodiments of the present invention.
  • the exemplary arrangement in Fig. 2 includes a light source 21 which can act as pump beam 23 and may be delivered to the sample 25 through a beam splitter 27, a beam scanner 29, and an objective lens 31.
  • the scattered light 33 can be collected by the objective lens 31, which may be a first element of a microscope arrangement 35, to obtain spatially resolved information.
  • Light can then be sent to a spectrometer 37 for spectral analysis and to a detector 39 to convert the optical information in electrical signals.
  • Possible light sources which may be used include, e.g., monochromatic lasers emitting a wavelength in the range of visible to infrared.
  • the light source can employ an optical arrangement to deliver more than one frequency line.
  • the linewidth of the laser may be typically less than about 1 MHz, which can provide temporal coherence longer than the lifetime of acoustic phonons.
  • the scattered light 33 from a sample may include multiple frequency components originated from simple elastic scattering, as well as Brillouin scattering.
  • Exemplary applications for microscope implementation include, e.g., wide-field or confocal microscopy, dual-axis confocal microscopy (see T. D. Wang, M. J. Mandella, C. H. Contag, and G. S. Kino, "Dual-axis confocal microscope for high-resolution in vivo imaging," Optics Letters, vol. 28, pp. 414-416, 2003) and/or fiber confocal microscopy.
  • an epi-detection configuration may be used in which a backward-propagating Brillouin light 33 is collected by the same lens 31 used for illumination.
  • Epi-detection can take advantage of an intrinsic property of Brillouin scattering, e.g., the scattered signal wave can be a phase conjugate to the pump wave. This property may enhance the collection efficiency of the Brillouin wave through a turbid medium such as tissue.
  • Exemplary focusing mechanisms are shown in Fig. 3.
  • a collimated pump beam with a relatively small beam diameter may be used.
  • the pump/probe beams can be focused to a sample by the use of objective lenses.
  • objective lenses with low numerical aperture (NA) 51 can result in a low transverse resolution, but the longitudinal interaction length may be long and well-defined.
  • objective lenses 53 having a high NA may provide better transverse and axial resolution. Since the Brillouin interaction length can be short and the interaction can be made over a large solid angle, the phase matching condition may become less stringent.
  • More than one pump beam may be provided using multiple objective lenses.
  • Fig. 4C depicts an exemplary embodiment of the present invention using two objective lenses 55, 57. This scheme, however, may not be suitable for in vivo biomedical applications.
  • Confocal techniques can be used to enhance depth sectioning. For example, a dual-axis confocal configuration can maximize axial resolution for a given NA and at the same time allows areduction of back-reflections and elastic scattering components.
  • a fiber arrangement can also be used, for example, by having a single-mode fiber as confocal pinhole. Acting as tight spatial mode filter, the fiber can provide strict confocal imaging which may reduce the amount of stray or spurious unwanted radiation.
  • Fabry-Perot interferometry can be used for the spectral analysis of Brillouin signal in both scanning (see J. R. Sandercock, "Some Recent Developments in Brillouin-Scattering," Rca Review, vol. 36, pp. 89-107, 1975) and non-scanning configurations (as described in K. J. Koski, J. Muller, H. D. Hochheimer, and J. L.
  • Fabry- Perot scanning interferometers can have very high resolution. However, they can be intrinsically slow because they perform the spectral analysis in a sequential manner by measuring the energy of the various frequency components one at a time. Non-scanning (or angle-dispersive) Fabry-Perot interferometry may be faster because it can measure all frequency components at once in a parallel fashion using an array of detectors. However, angle-dispersive Fabry-Perot interferometry may also have intrinsic limitations in sensitivity as described below.
  • the spectral separation can be determined by the interference of multiple reflections at two optical mirrors. Two interference patterns can be formed, one in transmission and one in reflection, but only the transmission pattern may be measured by the detecting device. All energy of the reflected interference pattern can be lost, thereby hindering the sensitivity of the spectrometer.
  • the maximum amount of light that may be forwarded to the detector in this configuration can be easily quantified.
  • the resolution performance of spectrally dispersive elements can be characterized by a parameter known as finesse (f), which may be defined as a ratio of the separation between different orders of diffraction to the linewidth of an individual resolved line.
  • a higher finesse can correspond to a higher resolution of the spectral dispersive element.
  • Fig. 4 A preferred solution for such spectroscopy is shown in Fig. 4, which includes a diffractive tilted etalon 71, e.g., a virtually-imaged phased array (VIPA) (see M. Shirasaki, "Large angular dispersion by a virtually imaged phased array and its application to a wavelength demultiplexer," Optics Letters, vol. 21, pp. 366-368, 1996), in combination with an array-type detector such as a CCD camera.
  • VIPA virtually-imaged phased array
  • the VTPA spectrometer can achieve high spectral resolution with high temporal resolution.
  • the spectral selection can be provided by the interference of multiple reflections at two optical flats, yielding equivalent performances in terms of resolution.
  • the first surface can be totally reflective but may be cut (or coated) to allow all the light to enter the interferometer. Besides minimizing losses, this design can avoid useful light being wasted in a reflected interference pattern.
  • the signal strength can be improved by a factor f equal to the finesse of the interferometer.
  • Such improvement in light throughput of the spectrometer can allow real time monitoring of dynamical processes such as collagen cross-linking.
  • the exemplary VIPA spectrometer generally may have a limited resolution of about 1 GHz and a limited extinction efficiency of about 30 dB (1 over a thousand) and, as a result, may be effective only for optically transparent samples.
  • elastic (Rayleigh) scattering can be several orders of magnitude stronger than Brillouin scattering and is separated by only a few GHz from Brillouin signal. For this reason, additional spectral selection may be preferable.
  • Possible solutions include diffraction gratings, fiber Bragg gratings, or notch filters based on narrow absorption line of gas cells. Two further procedures may be used, e.g., a multiple VIPA spectrometer and a spatial-to- spectral VTPA notch filter.
  • Fig. 5 shows a schematic illustration of an exemplary embodiment of a tandem- VTPA spectrometer.
  • the exemplary role of the first-stage VIPA 91 in this figure can be to provide spectral dispersion along a vertical axis.
  • a lens 93 can transfer this vertically dispersed beam to the second stage VTPA 95.
  • the second-stage VIPA can further disperse the beam, but along the horizontal direction.
  • the tail of the Rayleigh spectrum which had been overlapped with Brillouin peaks, may be separated from the Brillouin signals.
  • the resulting spectrum can be imaged by a lens 97 onto a 2D CCD array 99 or a ID array oriented at 45 degrees.
  • a spatial mask may be placed to reject Rayleigh light and to prevent it from entering the second VTPA.
  • the addition of the second VIPA may likely lead to an about 20- 25 dB improvement of contrast suppression.
  • This approach can be extended further to three or more VTPA stages to improve contrast, but additional stages may increase optical loss.
  • additional stages may increase optical loss.
  • a single VIPA stage can produce multiple diffraction orders, but only one or a few of them may be transferable to another VIPA at the next stage. Even with optimal optical design, a total loss of 6 to 10 dB may result.
  • additional losses can be compensated by increasing CCD integration time or by spectrum averaging.
  • improving the extinction of the spectrometer greatly reduces the problem arising from the backscattered light, thereby allowing for more efficient collection procedures.
  • Fig. 6 shows an exemplary spatial-to-spectral VDPA notch filter that can be used to selectively attenuate Rayleigh light with respect to Brillouin light.
  • the output of the collection optical system 111 can enter a VIPA 113 and become spectrally separated.
  • a spatial mask 115 can be placed at the back focal plane of an imaging lens 117 and may block the Rayleigh light.
  • the rest of the spectrum can be reflected by a mirror 119 and combined by the same VIPA 113 to exit the device 121 unchanged, apart from being spectrally filtered.
  • Combining a polarization beam splitter 123 and a quarter wave plate 125 can eliminate beam- splitting loss.
  • An additional extinction efficiency of -20 dB can be expected by such spectral notch filter.
  • a scanning filter such as a Fabry-Perot interferometer can be used.
  • the Fabry-Perot scanning interferometer may have a free spectral range of 50 GHz, and finesse of 1000; it can operate in single-pass configuration or in multipass, fixed or tandem, to enhance contrast.
  • a fixed filter with a bandpass, notch, or edge type may be used, instead of a scanning filter, to measure the magnitude of certain frequency components.
  • an optical frequency of the pump wave should be stabilized or locked with respect to the fixed filter.
  • Further exemplary embodiments of the present invention can be provided which combine exemplary embodiments described herein above with different spectral modalities. For example, once light is delivered to a material, the light collected from the sample can include various components arising from different phenomena which may carry independent information about the sample under study.
  • Fig. 7 shows an example of various components of such collected light separated by their frequency shift with respect to the incoming light.
  • reflected light 131 unshifted in frequency
  • a Brillouin component 133 can provide mechanical information about the sample.
  • Raman components 135 can arise from vibrational phonons of the analyzed material, and thus yield chemical information about its constituents.
  • Fluorescence 137 either endogenous or induced by the introduction of fluorophores, can help identify particular elements in the material and can provide functional information about the sample under scrutiny.
  • Raman scattering arising from rotational degrees of freedom of the sample can be analyzed as well as Rayleigh-Wing scattering, a process related to the optical anisotropy of the material, e.g., the fluctuations in the orientation of its molecules.
  • Reflectance, Raman and fluorescence spectroscopy can be used individually for imaging purposes, and a combination of two or more of such modalities may also be used.
  • a combination of Brillouin microscopy with other modalities can be provided.
  • An exemplary block diagram of such multi-modal microscopy via the simultaneous implementation of Brillouin as well as Raman and fluorescence spectroscopy is shown in Fig. 8.
  • fluorescence, Raman and Brillouin spectra can be in different regions of the electromagnetic spectrum after passing through the collection optics 151.
  • Scattered and fluorescent light 153 can undergo a coarse spectral dispersion 155 to separate the Brillouin, reflectance and rotational Raman components 157 from the fluorescence and vibrational Raman beam components 159.
  • Possible solutions for such coarse spectral dispersion can include, but are not limited to, gratings, dichroic mirrors and/or interferometric bandpass filters.
  • Beam 157 containing Brillouin reflectance and rotational Raman information
  • Exemplary solutions for this analysis can include various spectrometers as described herein above.
  • Beam 159 containing fluorescence and Raman scattering, can be further spectrally separated by a dispersive element 163, whose exemplary implementations are gratings, bandpass filters , prisms or other conventional spectral dividing methods.
  • the fluorescence beam 165 is collected and measured by a detector 167; the vibrational Raman component 169 is collected and measured by a detector 171.
  • Exemplary solutions for detectors 169, 171, 162 include, but are not limited to, photomultiplier tubes or photodiodes, or they can be combined in a single array detector such as, e.g., a CCD camera. Such detectors can allow delivery of Raman, Brillouin and fluorescent information simultaneously to the same computer 173.
  • This multi-modality technique and apparatus can be particularly advantageous because, as previously stated, the various processes can be used to sample independent and diverse characteristics of a given material, thus yielding mechanical as well as optical and/or chemical information about the analyzed sample.
  • Fig. 9 is a schematic diagram of a prototype instrument according to an exemplary embodiment of the present invention.
  • Such instrument includes a light source, imaging optics, a spectrometer, and a computer.
  • the light source is a frequency-doubled diode- pumped Nd-YAG laser emitting, e.g., a 532-nm wavelength with a linewidth of 1 MHz (Laser Quantum, Inc.)
  • Light is focused on a sample through a 30 mm focal length lens.
  • a dual-axis confocal geometry with a free-space entrance angle of about 6 degrees was chosen to minimize back-reflections and achieve higher sectioning capabilities with low numerical apertures (0.03). Scattered light is collected through the same lens.
  • a single mode fiber is then used as confocal pinhole. This allows for strict confocal imaging because the fiber is effectively a single-mode spatial filter, thus it minimizes stray light.
  • the output of the fiber is spectrally filtered by a 3 run bandpass filter, mainly to avoid fluorescence from the samples.
  • Light is then coupled into the VTPA spectrometer for high spatial separation of the spectral components in the plane of an Electron-Multiplied CCD camera.
  • the optical design of the spectrometer with the combination of input cylindrical lens before the VEPA and spherical lens after the VIPA as well as CCD binning, can maximize the SNR of the setup by achieving one-dimensional spectral dispersion.
  • VTPA VTPA
  • the exemplary total light throughput of an exemplary VTPA spectrometer can be as high as 75% .
  • FIG. 1OA A typical spectrum recorded from water in 1 s under 10 mW of illumination power is shown in Figs. lOA-lOC.
  • Fig. 1OA shows the central peak in each order, which can correspond to the elastic Rayleigh scattering, and the ancillary peaks on the right and on the left which can correspond to Stokes and anti-Stokes components of Brillouin scattering.
  • the acquired spectrum can be mapped onto an actual frequency scale as shown, e.g., in Fig. 1OC, to allow for the evaluation of Brillouin frequency shift and linewidth.
  • Fig. 11 Several spectra acquired from different materials using this prototype instrument are shown in Fig. 11.
  • BaBb (2:1 solution of Benzene and Benzyl alcohol) may be particularly relevant for future biological studies because it is a clearing agent widely used to achieve optical transparency in numerous biological samples.
  • the experimental data dots
  • the experimental data are fitted to a triplet of Lorentzian functions (solid line) while a fit of the single Stokes Brillouin line is shown by the dashed lines.
  • Plexiglas has a Brillouin shift very close to half the FSR of the spectrometer. Thus, Brillouin peaks from neighbor orders may also be visible.
  • the graphs shown in Fig. 11 suggest that some materials, e.g., Toluene and BaBB, can exhibit a measurable background arising from Rayleigh-wing scattering.
  • Fig. 12 shows a histogram of the occurrence of retrieved shifts as recorded over time from the same sample in the same experimental condition. This histogram thereby indicates the stability of Brillouin spectral analysis. The material used for this measurement is cured, fully solid, epoxy resin. Based on the histogram, the sensitivity of the instrument in the frequency (and thus elasticity) evaluation can be estimated (in this case, e.g., the sensitivity is about 20 MPa/ VHk ).
  • Rapid data acquisition achievable by parallel detection can be critical for following dynamic processes that may change the elastic properties of materials in real time.
  • Such a capability is shown in Fig. 13 with respect to a UV curable epoxy resin sample.
  • a UV lamp was used for this measurement, characterized by an output of 90 mW/cm 2 in the 300 nm-400 nm wavelength range, and placed 8 cm away from the sample.
  • a UV lamp was turned on to begin curing the resin.
  • the measurement of Brillouin shifts over time reveals rapid changes under UV light as well as a slow curing process afterward. No curing effect was observed based on the incident green light, as suggested by the Brillouin signatures for t ⁇ 0 .
  • the elastic modulus changed from 4.5 GPa when uncured to 9 GPa after fully cured over 1 day.
  • Three-dimensional Brillouin microscopy can be achieved using exemplary embodiments of the present invention that include a confocal arrangement.
  • Brillouin spectra can be acquired continuously as the sample is translated with respect to the beam focus.
  • the spatial resolution of an exemplary confocal apparatus was observed to be about 6 ⁇ m in a transverse direction and 60 ⁇ m in an axial direction.
  • Resolution measurements were obtained by recording Brillouin frequency shifts at the interface of two materials by over-sampling the acquisition data to a much smaller step than the actual resolution.
  • Brillouin signatures from both materials were observed, having different strengths depending on the amount of light that is shining onto a particular material.
  • a meaningful parameter retrieved for such measurement can be a ratio between Brillouin signal amplitudes in the two frequency regimes that correspond to the two different materials.
  • an intraocular polymer lens e.g., a popular biomedical implant used to replace a human crystalline lens
  • the intraocular lens is made of acrylate-methacrylate copolymer with bonded UV absorber and blue- light filtering chromophore (transmission of about 90% at 532nm) to mimic the performance of human lenses.
  • the intraocular lens was placed in a bath of epoxy resin of similar refractive index, inside a plastic cuvette, and the sample was slightly tilted with respect to the optical axis as shown in Fig 14 A.
  • Figs. 14B and 14C depict exemplary processed cross sectional images of an x-z plane of the lens.
  • Brillouin frequency shifts are color mapped vs. spatial position inside the sample.
  • the normalized Brillouin signal amplitude at a given frequency shift is color mapped vs. spatial position.
  • Brillouin amplitude which can be related to a material coupling of acoustic and optical energy, may be peculiar to each medium and can be used as additional signature for material discrimination.
  • the biconvex shape of the lens can be distinguished in these images, as well as small dust particles on the lens surface and the plastic cuvette in the top left coiner.
  • the extinction for a single VIPA spectrometer can be estimated to be about 34dB, with one for a tandem VTPA spectrometer possibly approaching about 59dB.
  • the total throughput of a tandem VIPA spectrometer can typically be about 50%.
  • a tandem VIPA spectrometer it may be possible to measure, e.g., the Brillouin signature from crystalline lens of a mouse eye in vivo.
  • Fig.. 16A depicts the exemplary geometry of the measurement and the exemplary anatomy of the murine eyeball.
  • a coverslip may be placed on the anterior surface of the cornea with methylcellulose to minimize the corneal refraction.
  • the laser beam may enter the crystalline lens through the center of the pupil. It is possible to acquire Brillouin spectra along the optic axis of the eye, e.g., at a depth interval of about 100 ⁇ m, with approximately 5-mW optical power and about 3-s integration time.
  • FIG. 16B depicts the exemplary measured Brillouin frequency shift in an 18-month-old C57BL/6 mouse.
  • the Brillouin shifts of the aqueous and vitreous humors may be close to the one typical of distilled water.
  • the Brillouin shift can increase from the outer layers (cortices) toward the center (nucleus).
  • This exemplary result may be consistent with previous measurements of excised lenses in vitro (see Ref. [I]), obtained using a multipass F-P scanning interferometer with higher power levels of about 10-25 mW and a longer integration time of about 10 min per spectrum.
  • Fig.. 16C depicts a similar measurement as that performed shown in Fig..
  • Brillouin Microscopy can be used as a preferable noninvasive diagnostic tool in, e.g., ophthalmology for early diagnosis, treatment evaluation and scientific understanding of ocular diseases such as presbyopia and cataracts.
  • the exemplary embodiments of the present invention can also be used for various other applications, including and not limited to, e.g., auxiliary instruments for surgical treatments of cataracts, to monitor the procedure and/or evaluate pre- and post- surgical biomechanical signatures.
  • Exemplary embodiments of the present invention can be used in a variety of fields other than ophthalmology, as indicated by the preliminary exemplary data obtained using the exemplary embodiment of the system described herein above.
  • One such exemplary application may be, e.g., to follow real-time dynamical changes of mechanical properties of a material which can occur, e.g., in tissue engineering.
  • Exemplary embodiments of the present invention may facilitate more sophisticated studies and uses, such as characterizing the micromechanical environment of implanted chondrocytes and their effects on new cartilage formation in vivo and over time.
  • Brillouin spectra of a type-I collagen gel (0.8wt%) in 0.02N acetic acid solution and a photochemically cross-linked collagen-riboflavin mixture were measured.
  • Fig. 17 shows exemplary measured Brillouin spectra.
  • the large peaks centered at CCD pixel numbers 409, 437, and 465 correspond to elastic Rayleigh scattering, whereas other peaks in between originated from inelastic Brillouin scattering.
  • a tandem VIPA spectrometer may have a certain amount of a extinction to measure collagen cross-linking.
  • it is possible to prepare two acidic solutions with about 3% and 6% collagen, and measure their Brillouin signatures with and without crosslinking.
  • it may be preferable to use, e.g., Rose Bengal as a photo sensitizer; and the curing may occur with, e.g., 532 nm laser light.
  • Fig.. 18 depicts the exemplary results of this measurement. For example, 50 measurements with 10 mW illumination power and 2 seconds exposure may be preformed for each sample. As shown in Fig.
  • the exemplary embodiment of the apparatus according to the present invention is able to discriminate between, e.g., the control (non-cross-linked sample) and the cross-linked ones.
  • the control non-cross-linked sample
  • the cross-linked ones e.g., the control (non-cross-linked sample)
  • a distinction can be seen between the 3% and the 6% solution, e.g., showing enough sensitivity of the exemplary instrument to discriminate different tissue engineering compounds.
  • Brillouin microscopy may be useful, e.g., in reviewing and determining the mechanical properties and their effects on chondrocytes-encapsulated collagen scaffolds and neocartilage formation in vitro as well as in vivo.
  • Exemplary embodiments of the present invention may further be used to characterize living cells and tissues. However, stronger Rayleigh scattering arises in cells and tissue. An additional Rayleigh rejection efficiency of about 20-25 dB can be sufficient for tissue studies. Exemplary data may indicate that triple- VIPA spectrometer can be sufficient to achieve such exemplary task. Thus, Brillouin microscopy may be applied to biological tissues successfully.
  • Water has a bulk modulus, E, of about 2.2 GPa at room temperature and a density, p, of aboutl g/cm 3 .
  • E bulk modulus
  • p density
  • the energy of an acoustic wave involved in spontaneous Brillouin scattering may be too weak to cause any significant biological perturbation.
  • the Young's modulus and damping coefficient of a viscoelastic sample may be frequency dependent.
  • such parameters measured by Brillouin spectroscopy in the GHz frequency range may be different from those measured by conventional strain-stress test or dynamic mechanical analysis, which may be typically performed from 0 Hz (e.g., using DC signals) to 100 Hz, as described in R. L. Y. Sah, Y. J. Kim, J. Y. H. Doong, A. J. Grodzinsky, A. H. K. Plaas, and J. D. Sandy,
  • Measuring viscoelastic properties of living tissues using Brillouin microscopy can provide a useful clinical non-invasive tool for the detection of early-stage cancers or intra- operative determination of tumor margins.
  • Tumors may be generally stiffer than surrounding healthy tissue, and a Brillouin spectrum of a tumor can thereby exhibit a stronger magnitude than normal tissues at high frequencies .
  • Atherosclerosis is another medical area the Brillouin microscopy may be used for characterizing stress and tissue compliance, e.g., to help identify plaques which may be at risk for causing an acute coronary event.

Abstract

Exemplary embodiments of methods, arrangements and systems for obtaining information about a sample can be provided. For example, in one exemplary embodiment, it is possible to receive a first electro-magnetic radiation from a sample which is based on a second electro-magnetic radiation forwarded to the sample. The first electro-magnetic radiation may have a first frequency and the second electro-magnetic radiation may have a second frequency which is different from the first frequency. The difference between the first and second frequencies can be based on an acoustic wave inside the sample related to at least one characteristic of the sample. Further, it is possible to receive at least a portion of the first electromagnetic radiation and separate it into a particular finite number (N) of frequency component radiations. In addition, it is possible to receive a particular energy of more than 1/N of energy of the third electro-magnetic radiation, and generate information associated with the sample. Certain exemplary embodiments of the present invention are capable of obtaining information associated with a sample, particularly its mechanical properties, non- contact using electromagnetic radiation.

Description

METHODS, ARRANGEMENTS AND SYSTEMS FOR OBTAINING INFORMATION ASSOCIATED WITH A SAMPLE USING OPTICAL MICROSCOPY
CROSS-REFERENCE TO RELATED APPLICATIONCS) [0001] This application is based upon and claims the benefit of priority from U.S. Patent Application Serial No. 60/915,990, filed May 4, 2007, the entire disclosure of which is incorporated herein by reference.
FIELD OF THE INVENTION
[0002] The present invention relates to methods, arrangements and systems which can obtain acoustic information associated with a sample using electromagnetic radiation, and more particularly to such methods, systems and arrangements that can obtain viscoelastic properties of the sample by performing highly efficient Brillouin optical spectroscopy and imaging. This invention further relates to methods, arrangements and systems that combine Brillouin spectroscopy or imaging with reflectance, fluorescence, or Raman spectroscopy or imaging for simultaneous multimodal characterization of a sample.
BACKGROUND INFORMATION
[0003] When an electromagnetic radiation or an optical wave is propagated in a medium, it can be scattered inelastically by acoustic phonons inside the material. This process is known as Brillouin scattering. Brillouin scattering involves acoustic phonons, which may be different from Raman scattering that involves vibrational or rotational phonons.
[0004] Spontaneous Brillouin scattering involves acoustic phonons that may be present in a material by thermally-induced density fluctuations. Brillouin scattering can be further enhanced, stimulated, or forced by one or multiple optical pump waves with strong intensity. The magnitude and frequency of Brillouin-scattered light, or its optical spectrum, can be determined by characteristics of the acoustic phonons inside the material. The latter may be closely related to mechanical properties of the medium, such as modulus and hypersonic damping coefficient. Such viscoelastic properties therefore may be measurable by examining the Brillouin scattered light. This technique is referred to as Brillouin spectroscopy. Various techniques to detect the Brillouin signal have been widely applied in physics, material science, and mechanical engineering.
[0005] Prior Brillouin scattering studies have been also performed on biological samples, such as collagen fibers, cornea, and crystalline lens, ex vivo, as described in J. M. Vaughan and J. T. Randall, "Brillouin-Scattering, Density and Elastic Properties of the Lens and Cornea of the Eye," Nature, vol. 284, pp. 489-491, 1980, R. Harley, D. James, A. Miller, and J. W. White, "Phonons and Elastic-Moduli of Collagen and Muscle," Nature, vol. 267, pp. 285-287, 1977, and J. Randall and J. M. Vaughan, "Brillouin-Scattering in Systems of Biological Significance," Philosophical Transactions of the Royal Society of London Series a- Mathematical Physical and Engineering Sciences, vol. 293, pp. 341-348, 1979. However, the potential of using Brillouin scattering for tissue biomechanics and tissue engineering has not been significantly explored, possibly because of long acquisition times required by the spectral analysis.
[0006] Accordingly, there is a need to overcome the deficiencies described herein above, and to provide improved apparatus, systems and processes for analyzing tissue biomechanics using Brillouin techniques.
OBJECTS AND SUMMARY OF EXEMPLARY EMBODIMENTS
[0007] To address and/or overcome the above-described problems and/or deficiencies, exemplary embodiments of imaging systems, arrangements and processes can be provided that are capable of combining a rapid spectroscopic analysis of Brillouin scattering with high spatial-resolution microscopy to probe a sample such as human tissue or artificially engineered tissue or other natural and synthetic biomaterial and retrieve their biomechanical properties such as complex modulus at the tissue.
[0008] In one exemplary apparatus, a novel rapid yet high-resolution spectroscopic analysis can enable the image formation. A pump beam can be scanned over a sample through an objective lens, and Brillouin-shifted optical waves are detected to characterize their Brillouin spectra. The measured spectral features of the Brillouin signal can be used as contrast for imaging; an image can be obtained by use of a proper lookup table or an appropriate processing computational routine. Thin cross-sectional images of a biological sample can be obtained by using a high numerical-aperture objective lens and confocal detection.
[0009] In another exemplary apparatus in accordance with the present invention, the rapid spectral analysis can be multiplexed for different regimes. This can include empowering an optical microscope with different spectral modalities. Elastic scattering, Raman scattering, and/or fluorescence as well as Brillouin scattering from a sample can be simultaneously measured and three-dimensionally mapped to obtain a structural, chemical, functional as well as mechanical information of the sample.
[0010] Exemplary embodiments of the present invention provide apparatus and methods which can allow information about biomechanical properties of a material, particularly a biomaterial, to be obtained non-invasively. Such exemplary embodiments can find a wide range of applications in biology and medicine as well as tissue engineering. Potential applications of Brillouin microscopy include in situ, or in vivo, real-time characterization of collagen cross-linking, intraoperative characterizations of tissues based on biomechanical properties, in vivo disease diagnosis, intraoperative tumor margin determination, wound healing monitoring and/or tissue ablation monitoring. [0011] For example, using the exemplary embodiments of the present invention, it is possible to obtain the viscoelastic properties of a sample such as biomaterial, by performing highly efficient Brillouin optical spectroscopy or imaging. Further exemplary embodiments of the present invention can further relate to methods, arrangements and systems that combine Brillouin spectroscopy and imaging with reflectance, fluorescence, or Raman spectroscopy and imaging for simultaneous multimodal characterization of a sample.
[0012] Thus, in accordance with certain exemplary embodiments of the present invention, arrangements and methods are provided for obtaining information about a sample. For example, in one exemplary embodiment, it is possible (e.g., using a first arrangement) to receive a first electro-magnetic radiation from a sample which is based on a second electromagnetic radiation forwarded to the sample. The first electro-magnetic radiation can have a first frequency and the second electro-magnetic radiation has a second frequency which is different from the first frequency. The difference between the first and second frequencies can be based on an acoustic wave inside the sample related to at least one characteristic of the sample. For example, such difference can be is between about -100 GHz and +100 GHz and may be based on an acoustic wave inside the sample related to at least one characteristic of the sample. The first arrangement may employ a confocal pinhole or single-mode optical fiber.
[0013] Further exemplary embodiments of the present invention can facilitate (e.g., using a second arrangement) a receipt of at least a portion of the first electromagnetic radiation and separate such second electromagnetic radiation into a particular finite number (N) of frequency component radiations. For example, N can correspond to the number of spectrally resolvable elements and, typically, can range from about 10 to 100 for a Fabry-Perot interferometer or a diffractive grating. A plurality of such frequency component radiations can be simultaneously measured by an array of detectors, where the total combined energy of the frequency component radiations may be greater than 1/N times the energy of the received portion of the first electromagnetic radiation.
[0014] . In addition, according to the exemplary embodiment of the present invention, it is possible (e.g., using a third arrangement) to receive a particular energy of more than 1/N of energy of the third electro-magnetic radiation, and generate information associated with the sample.
[0015] According to another exemplary embodiment of the present invention, it is possible (e.g., using a fourth arrangement) to generate information associated with the sample and to create images of the sample based on the information. In addition, it is possible (e.g., using a fifth arrangement) to scan the second electromagnetic radiation or to move the sample to probe different locations in the sample.
[0016] According to another exemplary embodiment of the present invention, the information may be related to a difference between the first and second frequencies, an optical energy associated with a particular finite group of frequency component radiations, and/or a linewidth of a plurality of the frequency component radiations, each of which may be associated with a particular frequency. This linewidth can be equivalent to a linewidth of Brillouin scattering, which may be related to an acoustic damping coefficient of the sample. In contrast, a linewidth of each frequency component radiation can be equivalent to an intrinsic spectral resolution of the second arrangement such as, e.g., a spectrometer. The retrieved information can relate to bio-mechanical properties of the sample that include but are not limited to a complex modulus of the sample, a cross linking of collagen or another anatomical structure.
[0017] In a still further exemplary embodiment of the present invention, the first arrangement can include a narrow-band spectral filter arrangement which can receive the first electro- magnetic radiation and attenuate at least a portion thereof which has a frequency which is approximately the same as the second frequency.
[0018] Still further exemplary embodiments of the present invention can provide (e.g., using another first arrangement) for a receipt of a first electro-magnetic radiation and a second electro-magnetic radiation provided from a sample, where the first and second electromagnetic radiations may be based on a third electro-magnetic radiation forwarded to the sample. The first electro-magnetic radiation can have a first frequency, and the second electro-magnetic radiation can have a second frequency and the third electro-magnetic radiation can have a third frequency which may be different from the first frequency. A difference between the first and third frequencies can be based on an acoustic wave inside the sample which may be related to at least one characteristic of the sample. The second electromagnetic radiation can be based on at least one of an elastic scattering, a Raman scattering or a fluorescence within the sample.
[0019] In another exemplary embodiment of the present invention, it is possible (e.g., using such other first arrangement) to separate the first and second electro-magnetic radiations into first and second frequency component radiations, respectively. A narrow band spectral separating arrangement can be provided to separate the first electro-magnetic radiation, and a broadband spectral separating arrangement configured to separate the second electro-magnetic radiation. For example, it is possible (e.g., using another second arrangement) to simultaneously detect the first and second frequency component radiations, and to generate information associated with the sample based on the first and second frequency component radiations.
[0020] In another exemplary embodiment of the present invention, it is possible (e.g., using another third arrangement) to image the portion of the sample based on the information. [0021] These and other objects, features and advantages of the present invention will become apparent upon reading the following detailed description of embodiments of the invention, when taken in conjunction with the appended claims.
BRIEF DESCRIPTION OF THE DRAWINGS [0022] Further objects, features and advantages of the present invention will become apparent from the following detailed description taken in conjunction with the accompanying figures showing illustrative embodiments of the present invention, in which:
[0023] Fig. 1 is a schematic illustration of an exemplary Brillouin effect;
[0024] Fig. 2 is a block diagram of an exemplary apparatus which includes a scanning-beam Brillouin spectroscopy arrangement in accordance with certain exemplary embodiments of the present invention;
[0025] Fig. 3A is a first schematic illustration of an exemplary embodiment of a exemplary beam focusing procedure;
[0026] Fig. 3B is a second schematic illustration of an exemplary embodiment of a beam focusing procedure;
[0027] Fig. 3C is a third schematic illustration of an exemplary embodiment of a beam focusing procedure;
[0028] Fig. 4 is a schematic illustration of a parallel detection spectrometer arrangement in accordance with exemplary embodiments of the present invention;
[0029] Fig. 5 is a schematic illustration of a tandem parallel detection spectrometer arrangement in accordance with exemplary embodiments of the present invention; [0030] Fig. 6 is a schematic illustration of a narrowband spectral filter arrangement in accordance with exemplary embodiments of the present invention;
[0031] Fig. 7 is an exemplary graph of intensities of collected light in accordance with exemplary embodiments of the present invention;
[0032] Fig. 8 is a schematic illustration of an exemplary scanning-beam multi-modal spectroscopy - microscopy apparatus in accordance with exemplary embodiments of the present invention;
[0033] Fig. 9 is a schematic illustration of a prototype system in accordance with exemplary embodiments of the present invention;
[0034] Fig. 1OA is an illustration of an exemplary CCD pixel index in accordance with exemplary embodiments of the present invention;
[0035] Fig. 1OB is an exemplary analysis of spectral measurement of the index shown in Fig. 1OA;
[0036] Fig. 1OC is an illustration of an expanded view of a portion of the exemplary analysis of spectral measurement shown in Fig. 1 OB;
[0037] Fig. 11 is a further exemplary analysis of a spectral measurement in accordance with exemplary embodiments of the present invention;
[0038] Fig. 12 is an exemplary graph showing stability of a spectral analysis;
[0039] Fig. 13 is an exemplary graph showing a dynamic monitoring of a Brillouin shift in accordance with exemplary embodiments of the present invention; [0040] Fig. 14 A is an illustration of a biomaterial sample which was imaged in accordance with exemplary embodiments of the present invention;
[0041] Fig 14B is a first image obtained from the biomaterial sample shown in Fig. 14A in accordance with exemplary embodiments of the present invention;
[0042] Fig 14C is a second image obtained from the biomaterial sample shown in Fig. 14A in accordance with exemplary embodiments of the present invention;
[0043] Fig. 15A is an illustration of an exemplary Brillouin spectrum collected with a single- VIPA spectrometer in accordance with exemplary embodiments of the present invention;
[0044] Fig. 15B is an illustration of an exemplary Brillouin spectrum collected with a tandem VIPA spectrometer in accordance with exemplary embodiments of the present invention;
[0045] Fig. 16A is an illustration of the anatomy of a murine eyeball which was imaged in accordance with exemplary embodiments of the present invention;
[0046] Fig. 16B is a first exemplary measurement showing the depth profile of elasticity of a mouse eyeball measured in vivo in accordance with exemplary embodiments of the present invention;
[0047] Fig. 16C is a second exemplary measurement showing the depth profile of elasticity of a mouse eyeball measured in vivo in accordance with exemplary embodiments of the present invention;
[0048] Fig. 17 is an illustration of exemplary collagen samples and their corresponding Brillouin signatures determined in accordance with exemplary embodiments of the present invention; and [0049] Fig. 18 is an exemplary measurement of different Brillouin signatures for different concentration of collagen samples and different degrees of collagen cross-linking determined in accordance with exemplary embodiments of the present invention.
[0050] Throughout the figures, the same reference numerals and characters, unless otherwise stated, are used to denote like features, elements, components or portions of the illustrated embodiments. Moreover, while the subject invention will now be described in detail with reference to the figures, it is done so in connection with the illustrative embodiments. It is intended that changes and modifications can be made to the described embodiments without departing from the true scope and spirit of the subject invention as defined by the appended claims.
DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS
[0051] Fig. 1 illustrates the principle of Brillouin scattering which may be used in exemplary embodiments of the present invention. For example, monochromatic pump light 11 with a frequency vp - ωp 12π or wavelength λp - c l vp can be provided incident on a medium 13 to be tested, hi a spontaneous version of the process, the acoustic waves, due to thermally- induced density fluctuations inside the medium, can generate a periodic refractive index variation 15. Thus, the analyzed sample can be considered as being optically equivalent to a grating which is traveling at the velocity of sound. The scattered light 17 has a different direction because of Bragg-diffraction, and may be Doppler-shifted in frequency by an acoustic wavelength. It can have a spectral linewidth which may be determined by the inverse of the lifetime of the measured acoustic phonon. Both Stokes and anti-Stokes components, of lower and higher frequencies respectively, can be equally generated in the spontaneous process. [0052] The phase matching conditions between the pump and scattering light and the acoustic wave can be expressed as:
ωA = ωp - ωs . (1)
Figure imgf000012_0001
where ω and k are angular frequency and wave number, respectively, and the subscript A, p, and s represent the acoustic phonons, pump and scattering (or signal) photons, respectively.
[0053] The frequency of the phase matched phonons, e.g., a difference between the pump and scattering photons, can be expressed as:
InV . ( 0N v , = ±— — sm — (3)
where n is a refractive index of the sampled material, V is a sound velocity inside the medium, and θ is an angle between incident and scattered optical radiation. When the two waves propagate at the opposite direction, e.g., θ = 180 deg, the magnitude of Brillouin shift can attain a maximum value.
[0054] The linewidth of Brillouin radiation can be expressed as:
ΔvΛ = — , (4) n
where a represents an attenuation coefficient of the sound wave inside the sample.
[0055] The magnitude of the scattered radiation can provide additional information related to the coupling of acoustic and optical energy inside the sample and can be determined by the scattering cross section RB, as described in H. Z. Cummins and R. W. Gammon, "Rayleigh and Brillouin Scattering in Liquids - Landau-Placzek Ratio," Journal of Chemical Physics, vol. 44, pp. 2785-&, 1966.:
Figure imgf000013_0001
where V is the interaction volume inside the sample, k is the Boltzmann constant, T is the f β \2 temperature, p is the density of the material, and p — can represent an electrostriction
I dp) coefficient of the material.
[0056] Once the acoustic wave is initially developed, the Brillouin phenomenon may be accelerated because of the presence of the scattered light. The scattered light, coherent with the pump light, can amplify the resonant acoustic wave which in turn enhances the Brillouin scattering. This positive feedback can result in strong Brillouin shifted scattered light, a process which may be referred to as stimulated Brillouin scattering. Typically, a Stokes Brillouin component (e.g., having a frequency down shifted) may be predominantly generated in the stimulated scattering process. The process can also be enhanced or forced when two monochromatic pump waves with frequencies separated by vA are incident on a sample, as described in T. Sonehara and H. Tanaka, "Forced Brillouin Spectroscopy Using Frequency- Tunable Continuous-Wave Lasers," Physical Review Letters, vol. 75, pp. 4234-4237, 1995.. When the frequency difference is matched to one of the acoustic phonon frequencies in the sample, multiple Brillouin lines can be generated.
[0057] Brillouin interaction is typically a bulk phenomenon measuring bulk acoustic modes. However, as the sizes of the analyzed samples shrink or the opacity of materials increases, boundary effects can become significant in Brillouin scattering. Confined acoustic modes can be preferentially enhanced depending on the geometrical properties of analyzed environments such as size and shape of boundaries or of their individual constituents. An example of this effect is Brillouin scattering from thin films where optical radiation can be dominantly scattered by a surface acoustic wave that determines a dynamical deformation of the sample border known as surface-ripple, as described in R. Loudon, "Theory of Surface-Ripple Brillouin-Scattering by Solids," Physical Review Letters, vol. 40, pp. 581-583, 1978.. Recently, confined acoustic modes have also been observed in nanoparticles, as described in H. S. Lim, M. H. Kuok, S. C. Ng, and Z. K. Wang, "Brillouin observation of bulk and confined acoustic waves in silica microspheres," Applied Physics Letters, vol. 84, pp. 4182- 4184, 2004.. For example, empirically, the limit on the dimensions at which bulk Brillouin interactions may be observable has been evinced to be a few acoustic wavelengths, e.g., « λp 12« .
[0058] Brillouin spectroscopy is a technique that can measure a spectrum of Brillouin scattered light with respect to the pump waves, thereby probing the characteristics of acoustic phonons in a medium. Under certain conditions, it can serve as a mechanical fingerprint of the medium. For example, mechanically, Brillouin scattering can monitor the stress response of a sample to a one-dimensional sinusoidal strain of high frequency (GHz). For viscoelastic materials, the stress of the sample can be determined by a complex longitudinal modulus (M = M'+iM") whose real part expresses the elastic response and whose imaginary part expresses the viscous response, e.g., the loss of acoustic energy in the sample. The acoustic parameters directly measured (V and a) can be related to the longitudinal modulus through the density p of the material [3], e.g. :
M'= pV2 ; M"= 2pV3a/vB . (6)
[0059] In exemplary embodiments of the present invention, a two-dimensional or three- dimensional microscopic mapping of the mechanical properties of a material, in particular a biological sample, can be constructed by using rapidly acquired Brillouin spectroscopic signatures as contrast. In an exemplary embodiment of the present invention, a pump or probe beam may be scanned laterally across the sample and spectral patterns from each region are recorded to create an image. Light can be scanned with various conventional scanners including, e.g., galvanometer-mounted mirrors, polygonal mirror scanners and/or MEMS mirrors. Another exemplary embodiment of the present invention can use a scanning mechanism located on a fiber-optic catheter or endoscope for an application to, for example, luminal organ imaging.
[0060] In principle, three independent parameters can be extracted by each collected spectrum and can serve as contrast mechanisms for imaging: Brillouin frequency shift (Eq. 3), Brillouin linewidth (Eq. 4), and Brillouin intensity (Eq. 5). All of these three properties can have peculiar signatures (e.g., elasticity, viscosity and electrostriction, respectively) of the sampled material. Thus, three separate images can be obtained, for example, using a false color lookup table, featuring such properties. Alternatively, the three pieces of information can be used simultaneously for higher accuracy, especially at the interfaces between two different materials. For example, at the borders of the objects, a non-trivial imaging processing procedure can be applied rather than a simple false-color lookup table. At the interfaces,
Brillouin lines of both materials can be measured, proportionally to the amount of incident light that excites each particular material. Therefore, rather than relying on only one of the spectral signatures, the various Brillouin lines can be discriminated, and their total strength can be accurately quantified and compared to the strength that would be observed away from an interface.
[0061] Fig. 2 depicts a block diagram of an exemplary apparatus in accordance with exemplary embodiments of the present invention. The exemplary arrangement in Fig. 2 includes a light source 21 which can act as pump beam 23 and may be delivered to the sample 25 through a beam splitter 27, a beam scanner 29, and an objective lens 31. The scattered light 33 can be collected by the objective lens 31, which may be a first element of a microscope arrangement 35, to obtain spatially resolved information. Light can then be sent to a spectrometer 37 for spectral analysis and to a detector 39 to convert the optical information in electrical signals.
[0062] Possible light sources which may be used include, e.g., monochromatic lasers emitting a wavelength in the range of visible to infrared. The light source can employ an optical arrangement to deliver more than one frequency line. The linewidth of the laser may be typically less than about 1 MHz, which can provide temporal coherence longer than the lifetime of acoustic phonons. The scattered light 33 from a sample may include multiple frequency components originated from simple elastic scattering, as well as Brillouin scattering.
[0063] Exemplary applications for microscope implementation include, e.g., wide-field or confocal microscopy, dual-axis confocal microscopy (see T. D. Wang, M. J. Mandella, C. H. Contag, and G. S. Kino, "Dual-axis confocal microscope for high-resolution in vivo imaging," Optics Letters, vol. 28, pp. 414-416, 2003) and/or fiber confocal microscopy. In an exemplary embodiment of the present invention, an epi-detection configuration may be used in which a backward-propagating Brillouin light 33 is collected by the same lens 31 used for illumination. Epi-detection can take advantage of an intrinsic property of Brillouin scattering, e.g., the scattered signal wave can be a phase conjugate to the pump wave. This property may enhance the collection efficiency of the Brillouin wave through a turbid medium such as tissue.
[0064] Exemplary focusing mechanisms are shown in Fig. 3. For coarse resolutions, a collimated pump beam with a relatively small beam diameter may be used. However, for three dimensional resolutions, the pump/probe beams can be focused to a sample by the use of objective lenses. In the exemplary configuration of Fig. 3A, objective lenses with low numerical aperture (NA) 51 can result in a low transverse resolution, but the longitudinal interaction length may be long and well-defined. In Fig. 3B, objective lenses 53 having a high NA may provide better transverse and axial resolution. Since the Brillouin interaction length can be short and the interaction can be made over a large solid angle, the phase matching condition may become less stringent. This condition can broaden the linewidth of the scattered light, thereby affecting the strength of Brillouin signal and the accuracy of the spectral analysis, as described in Danielme.Hg, "Aperture Corrections for Sound-Absorption Measurements with Light Scattering," Journal of the Acoustical Society of America, vol. 47, pp. 151-&, 1970.
[0065] More than one pump beam may be provided using multiple objective lenses. Fig. 4C depicts an exemplary embodiment of the present invention using two objective lenses 55, 57. This scheme, however, may not be suitable for in vivo biomedical applications. Confocal techniques can be used to enhance depth sectioning. For example, a dual-axis confocal configuration can maximize axial resolution for a given NA and at the same time allows areduction of back-reflections and elastic scattering components. A fiber arrangement can also be used, for example, by having a single-mode fiber as confocal pinhole. Acting as tight spatial mode filter, the fiber can provide strict confocal imaging which may reduce the amount of stray or spurious unwanted radiation.
[0066] The requirements on spectral analysis for Brillouin spectroscopy can be stringent because 0.1 GHz to 50 GHz features may be resolved. High spectral resolution and rapid analysis can be essential to facilitate imaging capabilities as well as dynamic studies. [0067] High resolution and simultaneously high sensitivity in the spectral analysis can be important. Fabry-Perot interferometry can be used for the spectral analysis of Brillouin signal in both scanning (see J. R. Sandercock, "Some Recent Developments in Brillouin-Scattering," Rca Review, vol. 36, pp. 89-107, 1975) and non-scanning configurations (as described in K. J. Koski, J. Muller, H. D. Hochheimer, and J. L. Yarger, "High pressure angle-dispersive Brillouin spectroscopy: A technique for determining acoustic velocities and attenuations in liquids and solids," Review of Scientific Instruments, vol. 73, pp. 1235-1241, 2002). Fabry- Perot scanning interferometers can have very high resolution. However, they can be intrinsically slow because they perform the spectral analysis in a sequential manner by measuring the energy of the various frequency components one at a time. Non-scanning (or angle-dispersive) Fabry-Perot interferometry may be faster because it can measure all frequency components at once in a parallel fashion using an array of detectors. However, angle-dispersive Fabry-Perot interferometry may also have intrinsic limitations in sensitivity as described below.
[0068] In angle-dispersive Fabry-Perot spectroscopy, the spectral separation can be determined by the interference of multiple reflections at two optical mirrors. Two interference patterns can be formed, one in transmission and one in reflection, but only the transmission pattern may be measured by the detecting device. All energy of the reflected interference pattern can be lost, thereby hindering the sensitivity of the spectrometer.
[0069] The maximum amount of light that may be forwarded to the detector in this configuration can be easily quantified. The resolution performance of spectrally dispersive elements can be characterized by a parameter known as finesse (f), which may be defined as a ratio of the separation between different orders of diffraction to the linewidth of an individual resolved line. The finesse f can be similar to the number of spectral components can be resolved; e.g., f = N. A higher finesse can correspond to a higher resolution of the spectral dispersive element.
[0070] However, in angle dispersive Fabry-Perot interferometry, for each frequency component that is discriminated in the transmitted pattern, a certain, proportional, amount of light may be lost in the reflected pattern. Thus, a higher finessecan correspond to a lower total light throughput. If f is the finesse of the angle-dispersive Fabry-Perot interferometer, then a maximum of 1/f of the input light can be sent to the detecting device. This is a limit which does not include other practical loss mechanisms. The 1/f throughput limit can be overcome by various other spectral dispersive elements such as, e.g., diffraction gratings or prisms, but such devices cannot provide the high resolution needed for Brillouin spectroscopy.
[0071] The simultaneous requirements of resolution and light throughput can be met by a fully parallel-detection spectroscopic technique. A preferred solution for such spectroscopy is shown in Fig. 4, which includes a diffractive tilted etalon 71, e.g., a virtually-imaged phased array (VIPA) (see M. Shirasaki, "Large angular dispersion by a virtually imaged phased array and its application to a wavelength demultiplexer," Optics Letters, vol. 21, pp. 366-368, 1996), in combination with an array-type detector such as a CCD camera. Light can be focused on the VTPA element 71 by a cylindrical lens 75 while light is collected from the VTPA 71 onto the CCD by another lens 77. The VTPA spectrometer can achieve high spectral resolution with high temporal resolution. As in angle-dispersive Fabry-Perot spectroscopy, the spectral selection can be provided by the interference of multiple reflections at two optical flats, yielding equivalent performances in terms of resolution. Unlike Fabry-Perot etalons, however, the first surface can be totally reflective but may be cut (or coated) to allow all the light to enter the interferometer. Besides minimizing losses, this design can avoid useful light being wasted in a reflected interference pattern. As a consequence, with respect to an equivalent Fabry-Perot spectrometer, the signal strength can be improved by a factor f equal to the finesse of the interferometer. Such improvement in light throughput of the spectrometer can allow real time monitoring of dynamical processes such as collagen cross-linking.
[0072] the exemplary VIPA spectrometer generally may have a limited resolution of about 1 GHz and a limited extinction efficiency of about 30 dB (1 over a thousand) and, as a result, may be effective only for optically transparent samples. In a turbid sample such as a biological tissue, elastic (Rayleigh) scattering can be several orders of magnitude stronger than Brillouin scattering and is separated by only a few GHz from Brillouin signal. For this reason, additional spectral selection may be preferable. Possible solutions include diffraction gratings, fiber Bragg gratings, or notch filters based on narrow absorption line of gas cells. Two further procedures may be used, e.g., a multiple VIPA spectrometer and a spatial-to- spectral VTPA notch filter.
[0073] Fig. 5 shows a schematic illustration of an exemplary embodiment of a tandem- VTPA spectrometer. The exemplary role of the first-stage VIPA 91 in this figure can be to provide spectral dispersion along a vertical axis. A lens 93 can transfer this vertically dispersed beam to the second stage VTPA 95. The second-stage VIPA can further disperse the beam, but along the horizontal direction. After the second stage, the tail of the Rayleigh spectrum, which had been overlapped with Brillouin peaks, may be separated from the Brillouin signals. The resulting spectrum can be imaged by a lens 97 onto a 2D CCD array 99 or a ID array oriented at 45 degrees. A spatial mask may be placed to reject Rayleigh light and to prevent it from entering the second VTPA. The addition of the second VIPA may likely lead to an about 20- 25 dB improvement of contrast suppression.
[0074] This approach can be extended further to three or more VTPA stages to improve contrast, but additional stages may increase optical loss. Besides the intrinsic losses of a VIPA, a single VIPA stage can produce multiple diffraction orders, but only one or a few of them may be transferable to another VIPA at the next stage. Even with optimal optical design, a total loss of 6 to 10 dB may result. These additional losses can be compensated by increasing CCD integration time or by spectrum averaging. Moreover, improving the extinction of the spectrometer greatly reduces the problem arising from the backscattered light, thereby allowing for more efficient collection procedures.
[0075] Fig. 6 shows an exemplary spatial-to-spectral VDPA notch filter that can be used to selectively attenuate Rayleigh light with respect to Brillouin light. For example, the output of the collection optical system 111 can enter a VIPA 113 and become spectrally separated. A spatial mask 115 can be placed at the back focal plane of an imaging lens 117 and may block the Rayleigh light. The rest of the spectrum can be reflected by a mirror 119 and combined by the same VIPA 113 to exit the device 121 unchanged, apart from being spectrally filtered. Combining a polarization beam splitter 123 and a quarter wave plate 125 can eliminate beam- splitting loss. An additional extinction efficiency of -20 dB can be expected by such spectral notch filter.
[0076] For specific situations in which high spectral resolution and contrast are needed a scanning filter such as a Fabry-Perot interferometer can be used. The Fabry-Perot scanning interferometer may have a free spectral range of 50 GHz, and finesse of 1000; it can operate in single-pass configuration or in multipass, fixed or tandem, to enhance contrast. Alternatively, a fixed filter with a bandpass, notch, or edge type may be used, instead of a scanning filter, to measure the magnitude of certain frequency components. However, an optical frequency of the pump wave should be stabilized or locked with respect to the fixed filter. [0077] Further exemplary embodiments of the present invention can be provided which combine exemplary embodiments described herein above with different spectral modalities. For example, once light is delivered to a material, the light collected from the sample can include various components arising from different phenomena which may carry independent information about the sample under study.
[0078] Fig. 7 shows an example of various components of such collected light separated by their frequency shift with respect to the incoming light. For example, reflected light 131, unshifted in frequency, can provide information about the structure of the sample as a standard reflectance confocal microscope might do. A Brillouin component 133 can provide mechanical information about the sample. Raman components 135 can arise from vibrational phonons of the analyzed material, and thus yield chemical information about its constituents. Fluorescence 137, either endogenous or induced by the introduction of fluorophores, can help identify particular elements in the material and can provide functional information about the sample under scrutiny. In addition, in Brillouin spectral region, Raman scattering arising from rotational degrees of freedom of the sample can be analyzed as well as Rayleigh-Wing scattering, a process related to the optical anisotropy of the material, e.g., the fluctuations in the orientation of its molecules. Reflectance, Raman and fluorescence spectroscopy can be used individually for imaging purposes, and a combination of two or more of such modalities may also be used.
[0079] In exemplary embodiments of the present invention, a combination of Brillouin microscopy with other modalities can be provided. An exemplary block diagram of such multi-modal microscopy via the simultaneous implementation of Brillouin as well as Raman and fluorescence spectroscopy is shown in Fig. 8. For example, fluorescence, Raman and Brillouin spectra can be in different regions of the electromagnetic spectrum after passing through the collection optics 151. Scattered and fluorescent light 153 can undergo a coarse spectral dispersion 155 to separate the Brillouin, reflectance and rotational Raman components 157 from the fluorescence and vibrational Raman beam components 159. Possible solutions for such coarse spectral dispersion can include, but are not limited to, gratings, dichroic mirrors and/or interferometric bandpass filters.
[0080] Beam 157, containing Brillouin reflectance and rotational Raman information, can be analyzed by a spectrometer 161 and a detector 162. Exemplary solutions for this analysis can include various spectrometers as described herein above. Beam 159, containing fluorescence and Raman scattering, can be further spectrally separated by a dispersive element 163, whose exemplary implementations are gratings, bandpass filters , prisms or other conventional spectral dividing methods. The fluorescence beam 165 is collected and measured by a detector 167; the vibrational Raman component 169 is collected and measured by a detector 171. Exemplary solutions for detectors 169, 171, 162 include, but are not limited to, photomultiplier tubes or photodiodes, or they can be combined in a single array detector such as, e.g., a CCD camera. Such detectors can allow delivery of Raman, Brillouin and fluorescent information simultaneously to the same computer 173.
[0081] This multi-modality technique and apparatus can be particularly advantageous because, as previously stated, the various processes can be used to sample independent and diverse characteristics of a given material, thus yielding mechanical as well as optical and/or chemical information about the analyzed sample.
[0082] Fig. 9 is a schematic diagram of a prototype instrument according to an exemplary embodiment of the present invention. Such instrument includes a light source, imaging optics, a spectrometer, and a computer. The light source is a frequency-doubled diode- pumped Nd-YAG laser emitting, e.g., a 532-nm wavelength with a linewidth of 1 MHz (Laser Quantum, Inc.) Light is focused on a sample through a 30 mm focal length lens. A dual-axis confocal geometry with a free-space entrance angle of about 6 degrees was chosen to minimize back-reflections and achieve higher sectioning capabilities with low numerical apertures (0.03). Scattered light is collected through the same lens. A single mode fiber is then used as confocal pinhole. This allows for strict confocal imaging because the fiber is effectively a single-mode spatial filter, thus it minimizes stray light. The output of the fiber is spectrally filtered by a 3 run bandpass filter, mainly to avoid fluorescence from the samples. Light is then coupled into the VTPA spectrometer for high spatial separation of the spectral components in the plane of an Electron-Multiplied CCD camera. The optical design of the spectrometer, with the combination of input cylindrical lens before the VEPA and spherical lens after the VIPA as well as CCD binning, can maximize the SNR of the setup by achieving one-dimensional spectral dispersion. According to one exemplary embodiment of the present invention, it is possible to utilize a number of types of VTPA, e.g., (a) a custom-built 3-mm solid etalon made of fused silica, as shown in Fig. 4, with coatings of about Rl=99.9%; about R2=95%, about FSR= 33 GHz and finesses between about 40 and 60; and (b) a home-built air-spaced VIPA which can include two mirrors (e.g.,Rl=99.9%; R2=95%), variable FSR between about 1 and 40 GHz and finesses between about 10 and 20. The exemplary total light throughput of an exemplary VTPA spectrometer can be as high as 75% .
[0083] A typical spectrum recorded from water in 1 s under 10 mW of illumination power is shown in Figs. lOA-lOC. Several diffraction orders are visible in the CCD retrieved image shown in Fig. 1OA. Fig. 1OB shows the central peak in each order, which can correspond to the elastic Rayleigh scattering, and the ancillary peaks on the right and on the left which can correspond to Stokes and anti-Stokes components of Brillouin scattering. The acquired spectrum can be mapped onto an actual frequency scale as shown, e.g., in Fig. 1OC, to allow for the evaluation of Brillouin frequency shift and linewidth. [0084] Several spectra acquired from different materials using this prototype instrument are shown in Fig. 11. Among the various samples examined, BaBb (2:1 solution of Benzene and Benzyl alcohol) may be particularly relevant for future biological studies because it is a clearing agent widely used to achieve optical transparency in numerous biological samples. The experimental data (dots) are fitted to a triplet of Lorentzian functions (solid line) while a fit of the single Stokes Brillouin line is shown by the dashed lines. Plexiglas has a Brillouin shift very close to half the FSR of the spectrometer. Thus, Brillouin peaks from neighbor orders may also be visible. The graphs shown in Fig. 11 suggest that some materials, e.g., Toluene and BaBB, can exhibit a measurable background arising from Rayleigh-wing scattering. The measured spectral width of Rayleigh-wing scattering in Toluene (8 cm"1) is consistent with previously observed data, as described in K. J. Koski, J. Muller, H. D. Hochheimer, and J. L. Yarger, "High pressure angle-dispersive Brillouin spectroscopy: A technique for determining acoustic velocities and attenuations in liquids and solids," Review of Scientific Instruments, vol. 73, pp. 1235-1241, 2002. Acquiring several spectra from different known materials can be used to calibrate spectral separations with respect to the actually observed spatial discrimination of different peaks, as described in the K. J. Koski reference. A linear relationship can be observed between measured pixel separation and literature data on Brillouin frequency shifts. Using the slope of such curves, the spectrometer can be calibrated. With such calibration, the Brillouin analysis on elasticity and viscosity retrieval can exhibit agreement with reported values, as described in the H. Z. Cummins and R. W. Gammon reference, the K. J. Koski reference, and G. W. Fans, L. E. Jusinski, and A. P. Hickman, "High-Resolution Stimulated Brillouin Gain Spectroscopy in Glasses and Crystals," Journal of the Optical Society of America B-Optical Physics, vol. 10, pp. 587-599, 1993
[0085] Fig. 12 shows a histogram of the occurrence of retrieved shifts as recorded over time from the same sample in the same experimental condition. This histogram thereby indicates the stability of Brillouin spectral analysis. The material used for this measurement is cured, fully solid, epoxy resin. Based on the histogram, the sensitivity of the instrument in the frequency (and thus elasticity) evaluation can be estimated (in this case, e.g., the sensitivity is about 20 MPa/ VHk ).
[0086] Rapid data acquisition achievable by parallel detection can be critical for following dynamic processes that may change the elastic properties of materials in real time. Such a capability is shown in Fig. 13 with respect to a UV curable epoxy resin sample. A UV lamp was used for this measurement, characterized by an output of 90 mW/cm2 in the 300 nm-400 nm wavelength range, and placed 8 cm away from the sample. At time t - 0 , a UV lamp was turned on to begin curing the resin. The measurement of Brillouin shifts over time reveals rapid changes under UV light as well as a slow curing process afterward. No curing effect was observed based on the incident green light, as suggested by the Brillouin signatures for t < 0 . The elastic modulus changed from 4.5 GPa when uncured to 9 GPa after fully cured over 1 day.
[0087] No previous data was available for comparison to such observations. However, the experimental result corresponds to the expected time-dependent curing process, because UV curing can induce crosslinking in a polymer adhesive and thereby increase its modulus. This experiment demonstrates the capability of exemplary embodiments of the present invention to monitor mechanical changes associated with crosslinking of a polymer with a high sensitivity (e.g., 40 MPa/VHz) and a high temporal resolution (e.g., about 1 sec).
[0088] Three-dimensional Brillouin microscopy can be achieved using exemplary embodiments of the present invention that include a confocal arrangement. For imaging, Brillouin spectra can be acquired continuously as the sample is translated with respect to the beam focus. The spatial resolution of an exemplary confocal apparatus was observed to be about 6 μm in a transverse direction and 60 μm in an axial direction. Resolution measurements were obtained by recording Brillouin frequency shifts at the interface of two materials by over-sampling the acquisition data to a much smaller step than the actual resolution. At the interface of two materials, Brillouin signatures from both materials were observed, having different strengths depending on the amount of light that is shining onto a particular material. A meaningful parameter retrieved for such measurement can be a ratio between Brillouin signal amplitudes in the two frequency regimes that correspond to the two different materials.
[0089] To demonstrate cross-sectional imaging, an intraocular polymer lens, e.g., a popular biomedical implant used to replace a human crystalline lens, was used as a sample. The intraocular lens is made of acrylate-methacrylate copolymer with bonded UV absorber and blue- light filtering chromophore (transmission of about 90% at 532nm) to mimic the performance of human lenses. To minimize backscattering and back-reflections, the intraocular lens was placed in a bath of epoxy resin of similar refractive index, inside a plastic cuvette, and the sample was slightly tilted with respect to the optical axis as shown in Fig 14 A. Such tilting can be seen by analyzing the processed image of the lens in Fig. 14B and 14C. To expedite the image acquisition and avoid unwanted curing effects in the resin, all the data of this experimental run were taken with 3.5 mW of illuminating power and 0.5 seconds of exposure time.
[0090] Figs. 14B and 14C depict exemplary processed cross sectional images of an x-z plane of the lens. In Fig. 14B, Brillouin frequency shifts are color mapped vs. spatial position inside the sample. In Fig. 14C, the normalized Brillouin signal amplitude at a given frequency shift is color mapped vs. spatial position. As suggested by Eq. (5), Brillouin amplitude, which can be related to a material coupling of acoustic and optical energy, may be peculiar to each medium and can be used as additional signature for material discrimination. The biconvex shape of the lens can be distinguished in these images, as well as small dust particles on the lens surface and the plastic cuvette in the top left coiner.
[0091] Certain previous exemplary data have been collected with a single VIPA spectrometer. Thus, such data may be limited to optical transparent samples. According to one exemplary embodiment of the present invention, by using an exemplary tandem VIPA spectrometer, the extinction can be improved significantly and therefore more scattering samples can be analyzed. Figs. 15A-15C show exemplary acquired Brillouin spectrum for Methanol using a single (see Fig. 15A) vs a tandem (see Fig. 15B) VTPA spectrometer featuring substantially two identical VIPAs with FSR= about 33 GHz and nominal coating reflectivities of about 99.9% and 95%. At half FSR, the extinction for a single VIPA spectrometer can be estimated to be about 34dB, with one for a tandem VTPA spectrometer possibly approaching about 59dB. The total throughput of a tandem VIPA spectrometer can typically be about 50%.
[0092] Using an exemplary tandem VIPA spectrometer, it may be possible to measure, e.g., the Brillouin signature from crystalline lens of a mouse eye in vivo. Fig.. 16A depicts the exemplary geometry of the measurement and the exemplary anatomy of the murine eyeball. For example, a coverslip may be placed on the anterior surface of the cornea with methylcellulose to minimize the corneal refraction. The laser beam may enter the crystalline lens through the center of the pupil. It is possible to acquire Brillouin spectra along the optic axis of the eye, e.g., at a depth interval of about 100 μm, with approximately 5-mW optical power and about 3-s integration time. Fig.. 16B depicts the exemplary measured Brillouin frequency shift in an 18-month-old C57BL/6 mouse. For example, the Brillouin shifts of the aqueous and vitreous humors may be close to the one typical of distilled water. In the crystalline lens, the Brillouin shift can increase from the outer layers (cortices) toward the center (nucleus). This exemplary result may be consistent with previous measurements of excised lenses in vitro (see Ref. [I]), obtained using a multipass F-P scanning interferometer with higher power levels of about 10-25 mW and a longer integration time of about 10 min per spectrum. Fig.. 16C depicts a similar measurement as that performed shown in Fig.. 16B except that it was performed on a 1 -month-old C57BL/6 mouse. The basic features of the measurement remain mostly the same, other than the physiological enlargement of the physical size of the eye. However, the stiffness of the crystalline lens is likely remarkably higher in the older mouse. This measurement likely indicates the ability of our instrument to detect changes in the mechanical properties of crystalline lenses with age, and illustrates the likely use of the exemplary embodiments of the present invention, e.g., for ophthalmology studies related for example to presbyopia, cataracts, refractive surgery, etc.
[0093] Based on such exemplary data, Brillouin Microscopy can be used as a preferable noninvasive diagnostic tool in, e.g., ophthalmology for early diagnosis, treatment evaluation and scientific understanding of ocular diseases such as presbyopia and cataracts. The exemplary embodiments of the present invention can also be used for various other applications, including and not limited to, e.g., auxiliary instruments for surgical treatments of cataracts, to monitor the procedure and/or evaluate pre- and post- surgical biomechanical signatures.
[0094] Exemplary embodiments of the present invention can be used in a variety of fields other than ophthalmology, as indicated by the preliminary exemplary data obtained using the exemplary embodiment of the system described herein above. One such exemplary application may be, e.g., to follow real-time dynamical changes of mechanical properties of a material which can occur, e.g., in tissue engineering.
[0095] For instance, injury to articular cartilage is a common orthopedic problem, with more than one million surgical procedures being performed in the United States each year. Tissue engineering offers new strategies for repairing cartilage, for example, by using chondrocytes and scaffolds to promote a formation of new cartilage matrix that closely resembles native tissue. Cartilage has an important biomechanical function. Consequently, the biomechanical properties of a scaffold and the micromechanical environment it provides for the implanted cells can play a significant role in cartilage repair. Although conventional mechanical testing techniques are widely used for such scaffolds, they can be invasive, time consuming, and difficult to use in situ and in vivo.
[0096] Exemplary embodiments of the present invention may facilitate more sophisticated studies and uses, such as characterizing the micromechanical environment of implanted chondrocytes and their effects on new cartilage formation in vivo and over time. In order to assess the feasibility of applying dynamic visco-elastic characterization for such cartilage formation, Brillouin spectra of a type-I collagen gel (0.8wt%) in 0.02N acetic acid solution and a photochemically cross-linked collagen-riboflavin mixture were measured. Fig. 17 shows exemplary measured Brillouin spectra. The large peaks centered at CCD pixel numbers 409, 437, and 465 correspond to elastic Rayleigh scattering, whereas other peaks in between originated from inelastic Brillouin scattering. Rayleigh scattering in the collagen solution was substantially stronger than that in water, producing larger background under the Brillouin peaks. Nevertheless, well-defined Brillouin peaks are observed with Brillouin shifts nearly the same as that of water, consistent with the high water content (-99%) in the gel. Additional peaks at a shift of about 3.5 GHz are also observed, although it may not be clear what these peaks represent. Mixing collagen gel with riboflavin further increased the Rayleigh peak (data not shown).
[0097] Crosslmking of the gel was induced by illuminating with blue light for 40 sec. After crosslinking, strong Rayleigh scattering, appreciable even with the naked eye, was observed to dominate nearly the entire spectral window, which may prohibit an accurate detection of Brillouin peaks.
[0098] A tandem VIPA spectrometer may have a certain amount of a extinction to measure collagen cross-linking. In order to demonstrate this ability, it is possible to prepare two acidic solutions with about 3% and 6% collagen, and measure their Brillouin signatures with and without crosslinking. In this exemplary case, it may be preferable to use, e.g., Rose Bengal as a photo sensitizer; and the curing may occur with, e.g., 532 nm laser light. Fig.. 18 depicts the exemplary results of this measurement. For example, 50 measurements with 10 mW illumination power and 2 seconds exposure may be preformed for each sample. As shown in Fig. 18, the exemplary embodiment of the apparatus according to the present invention is able to discriminate between, e.g., the control (non-cross-linked sample) and the cross-linked ones. In addition, a distinction can be seen between the 3% and the 6% solution, e.g., showing enough sensitivity of the exemplary instrument to discriminate different tissue engineering compounds.
[0099] Based on this exemplary data, Brillouin microscopy may be useful, e.g., in reviewing and determining the mechanical properties and their effects on chondrocytes-encapsulated collagen scaffolds and neocartilage formation in vitro as well as in vivo. Exemplary embodiments of the present invention may further be used to characterize living cells and tissues. However, stronger Rayleigh scattering arises in cells and tissue. An additional Rayleigh rejection efficiency of about 20-25 dB can be sufficient for tissue studies. Exemplary data may indicate that triple- VIPA spectrometer can be sufficient to achieve such exemplary task. Thus, Brillouin microscopy may be applied to biological tissues successfully. Water has a bulk modulus, E, of about 2.2 GPa at room temperature and a density, p, of aboutl g/cm3. Thus, e.g., at λ=532 nm, n=1.33, and θ=0°, and Δv = 7.5 GHz. Since water is the most abundant molecule in biological tissue, studies show that biological tissue can exhibit Brillouin shifts in a range of about 2-20 GHz at λ=532 nm, as described in the J. M. Vaughan and J. T. Randall publication and the R. Harley, D. James, A. Miller, and J. W. White publication. Most biopolymers, such as PMMA or acrylate polymer, have Brillouin shifts also in the GHz range. Non-isotropic samples such as muscle or collagen fibers can produce multiple Brillouin shifts, which may depend on the scattering direction with respect to their symmetry axes, as described in N. Berovic, N. Thomas, R. A. Thornhill, and J. M. Vaughan, "Observation of Brillouin-Scattering from Single Muscle-Fibers," European Biophysics Journal with Biophysics Letters, vol. 17, pp. 69-74, 1989. .
[00100] The energy of an acoustic wave involved in spontaneous Brillouin scattering may be too weak to cause any significant biological perturbation. The Young's modulus and damping coefficient of a viscoelastic sample may be frequency dependent. Thus, such parameters measured by Brillouin spectroscopy in the GHz frequency range may be different from those measured by conventional strain-stress test or dynamic mechanical analysis, which may be typically performed from 0 Hz (e.g., using DC signals) to 100 Hz, as described in R. L. Y. Sah, Y. J. Kim, J. Y. H. Doong, A. J. Grodzinsky, A. H. K. Plaas, and J. D. Sandy,
"Biosynthetic Response of Cartilage Explants to Dynamic Compression," Journal of
Orthopaedic Research, vol. 7, pp. 619-636, 1989. . Most biological tissue and biopolymers can be viscoelastic and, consequently, the elasticity may vary considerably with strain rate and temperature. Therefore, it can be important to establish a correlation between Brillouin measurements and conventional mechanical measurements. In contrast, water has a very rapid relaxation time, shorter than about 10 ps, so its elastic modulus may not vary much from 0 Hz to 10 GHz.
[00101] Measuring viscoelastic properties of living tissues using Brillouin microscopy can provide a useful clinical non-invasive tool for the detection of early-stage cancers or intra- operative determination of tumor margins. Tumors may be generally stiffer than surrounding healthy tissue, and a Brillouin spectrum of a tumor can thereby exhibit a stronger magnitude than normal tissues at high frequencies . Atherosclerosis is another medical area the Brillouin microscopy may be used for characterizing stress and tissue compliance, e.g., to help identify plaques which may be at risk for causing an acute coronary event.
[00102] [0055] The foregoing merely illustrates the principles of the invention. Various modifications and alterations to the described embodiments will be apparent to those skilled in the art in view of the teachings herein. Indeed, the arrangements, systems and methods according to the exemplary embodiments of the present invention can be used with any OCT system, OFDI system or other imaging systems, and for example with those described in U.S. Provisional Patent Appn. No. 60/514,769 filed October 27, 2003, and International Patent Application No. PCT/US03/02349 filed on January 24, 2003, the disclosures of which are incorporated by reference herein in their entireties. It will thus be appreciated that those skilled in the art will be able to devise numerous systems, arrangements and methods which, although not explicitly shown or described herein, embody the principles of the invention and are thus within the spirit and scope of the present invention. In addition, to the extent that the prior art knowledge has not been explicitly incorporated by reference herein above, it is explicitly being incorporated herein in its entirety. All publications referenced herein above are incorporated herein by reference in their entireties. Exemplary references cited herein are as follows: [1] J. M. Vaughan and J. T. Randall, "Brillouin-Scattering, Density and Elastic Properties of the Lens and Cornea of the Eye," Nature, vol. 284, pp. 489-491, 1980.
[2] R. Harley, D. James, A. Miller, and J. W. White, "Phonons and Elastic-Moduli of Collagen and Muscle," Nature, vol. 267, pp. 285-287, 1977. [3] J. Randall and J. M. Vaughan, "Brillouin-Scattering in Systems of Biological Significance," Philosophical Transactions of the Royal Society of London Series a- Mathematical Physical and Engineering Sciences, vol. 293, pp. 341-348, 1979.
[4] H. Z. Cummins and R. W. Gammon, "Rayleigh and Brillouin Scattering in Liquids - Landau-Placzek Ratio," Journal of Chemical Physics, vol. 44, pp. 2785-&, 1966.
[5] T. Sonehara and H. Tanaka, "Forced Brillouin Spectroscopy Using Frequency- Tunable Continuous-Wave Lasers," Physical Review Letters, vol. 75, pp. 4234-4237, 1995.
[6] R. Loudon, "Theory of Surface-Ripple Brillouin-Scattering by Solids," Physical Review Letters, vol. 40, pp. 581-583, 1978.
[7] H. S. Lim, M. H. Kuok, S. C. Ng, and Z. K. Wang, "Brillouin observation of bulk and confined acoustic waves in silica microspheres," Applied Physics Letters, vol. 84, pp. 4182- 4184, 2004.
[8] T. D. Wang, M. J. Mandella, C. H. Contag, and G. S. Kino, "Dual-axis confocal microscope for high-resolution in vivo imaging," Optics Letters, vol. 28, pp. 414-416, 2003.
[9] Daniehne.Hg, "Aperture Corrections for Sound- Absorption Measurements with Light Scattering," Journal of the Acoustical Society of America, vol. 47, pp. 151-&, 1970.
[10] J. R. Sandercock, "Some Recent Developments in Brillouin-Scattering," Rca Review, vol. 36, pp. 89-107, 1975.
[11] K. J. Koski, J. Muller, H. D. Hochheimer, and J. L. Yarger, "High pressure angle- dispersive Brillouin spectroscopy: A technique for determining acoustic velocities and attenuations in liquids and solids," Review of Scientific Instruments, vol. 73, pp. 1235-1241, 2002. [12] M. Shirasaki, "Large angular dispersion by a virtually imaged phased array and its application to a wavelength demultiplexer," Optics Letters, vol. 21, pp. 366-368, 1996.
[13] H. Tanaka and T. Sonehara, "New Method of Superheterodyne Light Beating Spectroscopy for Brillouin-Scattering Using Frequency-Tunable Lasers," Physical Review Letters, vol. 74, pp. 1609-1612, 1995.
[14] G. W. Faris, L. E. Jusinski, and A. P. Hickman, "High-Resolution Stimulated Brillouin Gain Spectroscopy in Glasses and Crystals," Journal of the Optical Society of America B- Optical Physics, vol. 10, pp. 587-599, 1993.
[15] N. Berovic, N. Thomas, R. A. Thornhill, and J. M. Vaughan, "Observation of Brillouin-Scattering from Single Muscle-Fibers," European Biophysics Journal with Biophysics Letters, vol. 17, pp. 69-74, 1989.
[16] R. L. Y. Sah, Y. J. Kim, J. Y. H. Doong, A. J. Grodzinsky, A. H. K. Plaas, and J. D. Sandy, "Biosynthetic Response of Cartilage Explants to Dynamic Compression," Journal of Orthopaedic Research, vol. 7, pp. 619-636, 1989.

Claims

WHAT IS CLAIMED IS:
1. An apparatus comprising: at least one first arrangement configured to receive at least one first electromagnetic radiation provided from a sample which is based on at least one second electro- magnetic radiation forwarded to the sample, wherein the at least one first electro-magnetic radiation has a first frequency and the at least one second electro-magnetic radiation has a second frequency which is different from the first frequency, and wherein a difference between the first and second frequencies is based on an acoustic wave inside the sample related to at least one characteristic of the sample; at least one second arrangement configured to receive at least one third electromagnetic radiation from the at least one first arrangement which is based on the at least one first electro-magnetic radiation and separate the at least one third electro-magnetic radiation into a particular finite number (N) of frequency component radiations; and at least one third arrangement configured to receive a particular energy of more than 1/N of energy of the at least one third electro-magnetic radiation, and generate information associated with the sample.
2. The apparatus according to paragraph 1, wherein the at least one third arrangement is configured to receive the particular energy of at least one particular radiation of the frequency component radiations.
3. The apparatus according to paragraph 1 , wherein the at least one third arrangement includes an array of detectors.
4. The apparatus according to paragraph 1, wherein the at least one second arrangement includes a virtually imaged phased array.
5. The apparatus according to paragraph 1 , wherein the particular number is between about 10 and 100.
6. The apparatus according to paragraph 1 , wherein the at least one third arrangement is configured to simultaneously receive a plurality of the frequency component radiations.
7. The apparatus according to paragraph 1, wherein the at least one first arrangement includes a narrow-band spectral filter arrangement which receives the at least one first electromagnetic radiation and attenuates at least one portion thereof which has a frequency which is approximately the same as the second frequency.
8. The apparatus according to paragraph 1, wherein the at least one first arrangement includes a single-mode optical fiber arrangement.
9. The apparatus according to paragraph 1 , wherein the at least one first arrangement includes a confocal arrangement.
10. The apparatus according to paragraph 1, wherein a resolvable linewidth of at least one frequency component radiation is less than 2 GHz.
11. The apparatus according to paragraph 1 , further comprising at least one fourth arrangement configured to image the at least one portion of the sample based on the information.
12. The apparatus according to paragraph 11 , wherein the information includes a difference between a frequency of at least one of the frequency component radiations and the second frequency.
13. The apparatus according to paragraph 12, wherein the difference is between approximately -100 GHz and +100 GHz.
14. The apparatus according to paragraph 11, wherein the information includes an energy of each of the frequency component radiations.
15. The apparatus according to paragraph 11, wherein the information includes a linewidth of a plurality of the frequency component radiations each of which heing associated with a particular frequency.
16. The apparatus according to paragraph 11, wherein the information includes at least one characteristic of the sample.
17. The apparatus according to paragraph 16, wherein the at least one characteristic includes at least one bio-mechanical property of the sample.
18. The apparatus according to paragraph 17, wherein the at least one bio-mechanical property includes complex viscoelastic modulus.
19. The apparatus according to paragraph 16, wherein the at least one characteristic includes a crosslinking of collagen in the sample.
20. The apparatus according to paragraph 11, wherein the sample includes at least one of an anatomical structure or a biomaterial.
21. The apparatus according to paragraph 1 , further comprising at least one fifth arrangement configured to deliver the at least one second electro-magnetic radiation to the sample.
22. The apparatus according to paragraph 21, wherein the at least one fifth arrangement scans the sample by moving the at least one second electro-magnetic radiation across the sample.
23. The apparatus according to paragraph 21, wherein the at least one fifth arrangement includes a fiber optic arrangement.
24. An apparatus comprising: at least one first arrangement configured to receive at least one first electro- magnetic radiation and at least one second electro-magnetic radiation provided from a sample, wherein the first and second electro-magnetic radiations which are based on at least one third electro-magnetic radiation forwarded to the sample, wherein the at least one first electromagnetic radiation has a first frequency , the at least one second electro-magnetic radiation has a second frequency and the at least one third electro-magnetic radiation has a third frequency which is different from the first frequency, wherein a difference between the first and third frequencies is based on an acoustic wave inside the sample related to at least one characteristic of the sample, wherein the at least one first arrangement is further configured to separate the first and second electro-magnetic radiations into first and second respective frequency component radiations; and at least one second arrangement configured to simultaneously detect the first and second frequency component radiations, and generate information associated with the sample based on the first and second frequency component radiations.
25. The apparatus according to paragraph 24, wherein the at least one second electromagnetic radiation is based on at least one of an elastic scattering, a vibrational Raman scattering or a fluorescence within the sample.
26. The apparatus according to paragraph 24, wherein the difference between the at least one first frequency and the at least one third frequency is greater than 10 THz.
27. The apparatus according to paragraph 24, further comprising at least one third arrangement configured to image the at least one portion of the sample based on the information.
28. The apparatus according to paragraph 24, wherein the at least one first arrangement includes a narrow band spectral separating arrangement for separating the at least one first electro-magnetic radiation, and a broadband spectral separating arrangement for separating the at least one second electro-magnetic radiation.
29. A method comprising: receiving at least one first electro-magnetic radiation provided from a sample which is based on at least one second electro-magnetic radiation forwarded to the sample, wherein the at least one first electro-magnetic radiation has a first frequency and the at least one second electro-magnetic radiation has a second frequency which is different from the first frequency, and wherein a difference between the first and second frequencies is based on an acoustic wave inside the sample related to at least one characteristic of the sample; receiving at least one third electro-magnetic radiation which is based on the at least one first electro-magnetic radiation and separate the at least one third electro-magnetic radiation into a particular finite number (N) of frequency component radiations; receiving a particular energy of more than 1/N of energy of the at least one third electro-magnetic radiation; and generating information associated with the sample.
30. A method comprising: receiving at least one first electro-magnetic radiation and at least one second electro-magnetic radiation provided from a sample, wherein the first and second electromagnetic radiations which are based on at least one third electro-magnetic radiation forwarded to the sample, wherein the at least one first electro-magnetic radiation has a first frequency, the at least one second electro-magnetic radiation has a second frequency and the at least one third electro-magnetic radiation has a third frequency which is different from the first frequency, and wherein a difference between the first and third frequencies is based on an acoustic wave inside the sample related to at least one characteristic of the sample; separating the first and second electro-magnetic radiations into first and second respective frequency component radiations; and simultaneously detecting the first and second frequency component radiations, and generate information associated with the sample based on the first and second frequency component radiations .
PCT/US2008/062354 2007-05-04 2008-05-02 Methods, arrangements and systems for obtaining information associated with a sample using brillouin microscopy WO2008137637A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91599007P 2007-05-04 2007-05-04
US60/915,990 2007-05-04

Publications (2)

Publication Number Publication Date
WO2008137637A2 true WO2008137637A2 (en) 2008-11-13
WO2008137637A3 WO2008137637A3 (en) 2009-01-08

Family

ID=39637589

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/062354 WO2008137637A2 (en) 2007-05-04 2008-05-02 Methods, arrangements and systems for obtaining information associated with a sample using brillouin microscopy

Country Status (2)

Country Link
US (1) US8115919B2 (en)
WO (1) WO2008137637A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109073459A (en) * 2016-02-12 2018-12-21 通用医疗公司 System for executing spectroscopy
WO2019036714A1 (en) 2017-08-18 2019-02-21 The General Hospital Corporation Systems and methods for brillouin spectroscopy and imaging of tissues
US11143555B2 (en) 2017-01-27 2021-10-12 University Of Maryland, College Park Methods and devices for reducing spectral noise and spectrometry systems employing such devices
US11408770B2 (en) 2017-10-30 2022-08-09 University Of Maryland, College Park Brillouin imaging devices, and systems and methods employing such devices

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1434522B1 (en) 2000-10-30 2010-01-13 The General Hospital Corporation Optical systems for tissue analysis
US7567349B2 (en) 2003-03-31 2009-07-28 The General Hospital Corporation Speckle reduction in optical coherence tomography by path length encoded angular compounding
US7447408B2 (en) 2004-07-02 2008-11-04 The General Hospital Corproation Imaging system and related techniques
KR20120062944A (en) 2004-08-24 2012-06-14 더 제너럴 하스피탈 코포레이션 Method and apparatus for imaging of vessel segments
EP1816949A1 (en) 2004-11-29 2007-08-15 The General Hospital Corporation Arrangements, devices, endoscopes, catheters and methods for performing optical imaging by simultaneously illuminating and detecting multiple points on a sample
EP1875436B1 (en) 2005-04-28 2009-12-09 The General Hospital Corporation Evaluation of image features of an anatomical structure in optical coherence tomography images
JP5702049B2 (en) 2005-06-01 2015-04-15 ザ ジェネラル ホスピタル コーポレイション Apparatus, method and system for performing phase resolved optical frequency domain imaging
ES2354287T3 (en) 2005-08-09 2011-03-11 The General Hospital Corporation APPARATUS AND METHOD FOR PERFORMING A DEMODULATION IN QUADRATURE BY POLARIZATION IN OPTICAL COHERENCE TOMOGRAPHY.
JP6046325B2 (en) 2005-09-29 2016-12-14 ザ ジェネラル ホスピタル コーポレイション Method and apparatus for the observation and analysis of one or more biological samples with progressively increased resolution
CN104257348A (en) 2006-01-19 2015-01-07 通用医疗公司 Methods And Systems For Optical Imaging Of Epithelial Luminal Organs By Beam Scanning Thereof
WO2007084903A2 (en) 2006-01-19 2007-07-26 The General Hospital Corporation Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and method for producing one or more optical arrangements
JP5524487B2 (en) 2006-02-01 2014-06-18 ザ ジェネラル ホスピタル コーポレイション A method and system for emitting electromagnetic radiation to at least a portion of a sample using a conformal laser treatment procedure.
EP1986545A2 (en) 2006-02-01 2008-11-05 The General Hospital Corporation Apparatus for applying a plurality of electro-magnetic radiations to a sample
WO2007101026A2 (en) 2006-02-24 2007-09-07 The General Hospital Corporation Methods and systems for performing angle-resolved fourier-domain optical coherence tomography
EP3150110B1 (en) 2006-05-10 2020-09-02 The General Hospital Corporation Processes, arrangements and systems for providing frequency domain imaging of a sample
WO2008049118A2 (en) 2006-10-19 2008-04-24 The General Hospital Corporation Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample and effecting such portion(s)
US8620155B2 (en) * 2007-06-14 2013-12-31 The University Of Sydney Optical signal to noise monitor
EP2274572A4 (en) 2008-05-07 2013-08-28 Gen Hospital Corp System, method and computer-accessible medium for tracking vessel motion during three-dimensional coronary artery microscopy
JP5667051B2 (en) 2008-07-14 2015-02-12 ザ ジェネラル ホスピタル コーポレイション Equipment for color endoscopy
WO2010090837A2 (en) 2009-01-20 2010-08-12 The General Hospital Corporation Endoscopic biopsy apparatus, system and method
WO2010091190A2 (en) 2009-02-04 2010-08-12 The General Hospital Corporation Apparatus and method for utilization of a high-speed optical wavelength tuning source
US11490826B2 (en) 2009-07-14 2022-11-08 The General Hospital Corporation Apparatus, systems and methods for measuring flow and pressure within a vessel
WO2011050164A1 (en) 2009-10-21 2011-04-28 Avedro, Inc. Eye therapy
US8804126B2 (en) 2010-03-05 2014-08-12 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
EP2547298B1 (en) * 2010-03-19 2019-05-08 Avedro, Inc. Systems for applying and monitoring eye therapy
US9069130B2 (en) 2010-05-03 2015-06-30 The General Hospital Corporation Apparatus, method and system for generating optical radiation from biological gain media
EP2575598A2 (en) 2010-05-25 2013-04-10 The General Hospital Corporation Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images
EP2575597B1 (en) 2010-05-25 2022-05-04 The General Hospital Corporation Apparatus for providing optical imaging of structures and compositions
US10285568B2 (en) 2010-06-03 2019-05-14 The General Hospital Corporation Apparatus and method for devices for imaging structures in or at one or more luminal organs
US9510758B2 (en) 2010-10-27 2016-12-06 The General Hospital Corporation Apparatus, systems and methods for measuring blood pressure within at least one vessel
US8744782B2 (en) * 2010-11-16 2014-06-03 Corning Incorporated System and method for simultaneously determining strain and temperature characteristics of an object
EP3838123A1 (en) * 2011-04-29 2021-06-23 The General Hospital Corporation Methods and arrangements for obtaining information and providing analysis for biological tissues
WO2012162529A1 (en) 2011-05-24 2012-11-29 Avedro, Inc. Systems and methods for reshaping an eye feature
JP6122845B2 (en) 2011-06-02 2017-04-26 アヴェドロ・インコーポレーテッドAvedro,Inc. System and method for monitoring the delivery of time-based photoactive agents or the presence of photoactive markers
US9330092B2 (en) 2011-07-19 2016-05-03 The General Hospital Corporation Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography
US8515289B2 (en) 2011-11-21 2013-08-20 Environmental Light Technologies Corp. Wavelength sensing lighting system and associated methods for national security application
EP2769491A4 (en) 2011-10-18 2015-07-22 Gen Hospital Corp Apparatus and methods for producing and/or providing recirculating optical delay(s)
JP2013205231A (en) * 2012-03-28 2013-10-07 Sumitomo Osaka Cement Co Ltd Brillouin scattering microscope
US9629528B2 (en) 2012-03-30 2017-04-25 The General Hospital Corporation Imaging system, method and distal attachment for multidirectional field of view endoscopy
WO2013177154A1 (en) 2012-05-21 2013-11-28 The General Hospital Corporation Apparatus, device and method for capsule microscopy
EP2872081B1 (en) 2012-07-16 2022-06-08 Avedro, Inc. Systems for corneal cross-linking with pulsed light
TWI456255B (en) * 2012-08-16 2014-10-11 Univ Nat Central Microscopy imaging structure with phase conjugated mirror and the method thereof
JP6227652B2 (en) 2012-08-22 2017-11-08 ザ ジェネラル ホスピタル コーポレイション System, method, and computer-accessible medium for fabricating a miniature endoscope using soft lithography
US9968261B2 (en) 2013-01-28 2018-05-15 The General Hospital Corporation Apparatus and method for providing diffuse spectroscopy co-registered with optical frequency domain imaging
WO2014120791A1 (en) 2013-01-29 2014-08-07 The General Hospital Corporation Apparatus, systems and methods for providing information regarding the aortic valve
WO2014121082A1 (en) 2013-02-01 2014-08-07 The General Hospital Corporation Objective lens arrangement for confocal endomicroscopy
EP2967491B1 (en) 2013-03-15 2022-05-11 The General Hospital Corporation A transesophageal endoscopic system for determining a mixed venous oxygen saturation of a pulmonary artery
WO2014186353A1 (en) 2013-05-13 2014-11-20 The General Hospital Corporation Detecting self-interefering fluorescence phase and amplitude
WO2014205145A1 (en) 2013-06-18 2014-12-24 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
EP3021735A4 (en) 2013-07-19 2017-04-19 The General Hospital Corporation Determining eye motion by imaging retina. with feedback
WO2015009932A1 (en) 2013-07-19 2015-01-22 The General Hospital Corporation Imaging apparatus and method which utilizes multidirectional field of view endoscopy
ES2893237T3 (en) 2013-07-26 2022-02-08 Massachusetts Gen Hospital Apparatus with a laser arrangement using optical scattering for applications in optical coherence tomography in the Fourier domain
US9733460B2 (en) 2014-01-08 2017-08-15 The General Hospital Corporation Method and apparatus for microscopic imaging
WO2015116986A2 (en) 2014-01-31 2015-08-06 The General Hospital Corporation System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device
WO2015153982A1 (en) 2014-04-04 2015-10-08 The General Hospital Corporation Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s)
EP3171766B1 (en) 2014-07-25 2021-12-29 The General Hospital Corporation Apparatus for in vivo imaging and diagnosis
CN107205845B (en) 2014-10-27 2020-03-31 艾维德洛公司 Systems and methods for cross-linking treatment of the eye
US9677935B2 (en) 2014-11-03 2017-06-13 Trutag Technologies, Inc. Fabry-perot spectral image measurement
WO2016077747A1 (en) 2014-11-13 2016-05-19 Avedro, Inc. Multipass virtually imaged phased array etalon
CN107250768A (en) * 2014-11-25 2017-10-13 欧瑞康表面解决方案股份公司,普费菲孔 The process monitoring hardened for UV
EP3827792A1 (en) 2015-04-24 2021-06-02 Avedro, Inc. Systems and methods for photoactivating a photosensitizer applied to an eye
EP3297589A4 (en) 2015-05-22 2019-03-06 Avedro Inc. Systems and methods for monitoring cross-linking activity for corneal treatments
EP3324973B1 (en) 2015-07-21 2020-06-03 Avedro, Inc. Treament of an eye with a photosensitizer
US10952608B2 (en) 2015-09-02 2021-03-23 The General Hospital Corporation Performing a procedure based on monitored properties of biological tissues
US10921112B2 (en) * 2015-09-17 2021-02-16 Technion Research & Development Foundation Ltd. Reflectance confocal microscopy of blood cells
US10055959B1 (en) * 2015-10-06 2018-08-21 National Technology & Engineering Solutions Of Sandia, Llc Systems and methods for intrusion detection using GHz beams
US10732092B2 (en) 2015-12-22 2020-08-04 University Of Maryland, College Park Analysis of single cell mechanical phenotyping for metastatic detection
DE102015016730A1 (en) 2015-12-22 2017-06-22 Oerlikon Surface Solutions Ag, Pfäffikon UV curing device with split UV deflecting mirrors
US10386288B2 (en) 2015-12-22 2019-08-20 Canon U.S. Life Sciences, Inc. System and method of label-free cytometry based on Brillouin light scattering
US10598594B2 (en) 2015-12-22 2020-03-24 University Of Maryland Cell classification based on mechanical signature of nucleus
US10561404B2 (en) * 2016-07-01 2020-02-18 Olympus Scientific Solutions Americas Inc. Gapless calibration method for phased array ultrasonic inspection
GB2552195A (en) * 2016-07-13 2018-01-17 Univ Oxford Innovation Ltd Interferometric scattering microscopy
US10631726B2 (en) 2017-01-11 2020-04-28 Avedro, Inc. Systems and methods for determining cross-linking distribution in a cornea and/or structural characteristics of a cornea
EP3589196A4 (en) 2017-03-01 2020-12-23 University of Maryland, College Park Cell classification based on mechanical signature of nucleus
US10436758B2 (en) * 2017-06-16 2019-10-08 Xerox Corporation Method and apparatus for determining an ultraviolet (UV) cure level
DE102017115922C5 (en) * 2017-07-14 2023-03-23 Precitec Gmbh & Co. Kg Method and device for measuring and setting a distance between a machining head and a workpiece and associated method for regulation
EP3761928A1 (en) 2018-03-08 2021-01-13 Avedro, Inc. Micro-devices for treatment of an eye
WO2020136896A1 (en) * 2018-12-28 2020-07-02 株式会社ニコン Evaluation device and evaluation method
EP4009928A4 (en) 2019-08-06 2023-08-02 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
US11422029B1 (en) 2019-11-22 2022-08-23 Intelon Optics, Inc. Managing stability in spectroscopy measurement systems
TWI717980B (en) * 2020-01-21 2021-02-01 台灣積體電路製造股份有限公司 Method, apparatus and recording medium for sample preparation in microscopy
WO2022031815A1 (en) * 2020-08-04 2022-02-10 University Of Maryland, College Park Full-field brillouin microscopy systems and methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050046837A1 (en) * 2003-09-03 2005-03-03 Fujitsu Limited Spectroscopic apparatus

Family Cites Families (307)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2197470A (en) * 1931-12-12 1940-04-16 Bendix Prod Corp Clutch control mechanism
US2339754A (en) 1941-03-04 1944-01-25 Westinghouse Electric & Mfg Co Supervisory apparatus
US3090753A (en) 1960-08-02 1963-05-21 Exxon Research Engineering Co Ester oil compositions containing acid anhydride
US3164010A (en) * 1962-04-20 1965-01-05 Dow Chemical Co Paper core crush or compression tester and method
GB1257778A (en) 1967-12-07 1971-12-22
US3601480A (en) 1968-07-10 1971-08-24 Physics Int Co Optical tunnel high-speed camera system
JPS4932484U (en) 1972-06-19 1974-03-20
US3872407A (en) 1972-09-01 1975-03-18 Us Navy Rapidly tunable laser
JPS584481Y2 (en) 1973-06-23 1983-01-26 オリンパス光学工業株式会社 Naishikiyoushiyahenkankogakkei
FR2253410A5 (en) 1973-12-03 1975-06-27 Inst Nat Sante Rech Med
US3941121A (en) 1974-12-20 1976-03-02 The University Of Cincinnati Focusing fiber-optic needle endoscope
US3983507A (en) 1975-01-06 1976-09-28 Research Corporation Tunable laser systems and method
US3973219A (en) 1975-04-24 1976-08-03 Cornell Research Foundation, Inc. Very rapidly tuned cw dye laser
US4141362A (en) 1977-05-23 1979-02-27 Richard Wolf Gmbh Laser endoscope
US4224929A (en) 1977-11-08 1980-09-30 Olympus Optical Co., Ltd. Endoscope with expansible cuff member and operation section
GB2030313A (en) 1978-06-29 1980-04-02 Wolf Gmbh Richard Endoscopes
FR2448728A1 (en) 1979-02-07 1980-09-05 Thomson Csf ROTATING JOINT DEVICE FOR OPTICAL CONDUCTOR CONNECTION AND SYSTEM COMPRISING SUCH A DEVICE
US4295738A (en) 1979-08-30 1981-10-20 United Technologies Corporation Fiber optic strain sensor
US4300816A (en) 1979-08-30 1981-11-17 United Technologies Corporation Wide band multicore optical fiber
US4428643A (en) 1981-04-08 1984-01-31 Xerox Corporation Optical scanning system with wavelength shift correction
US5065331A (en) 1981-05-18 1991-11-12 Vachon Reginald I Apparatus and method for determining the stress and strain in pipes, pressure vessels, structural members and other deformable bodies
GB2106736B (en) 1981-09-03 1985-06-12 Standard Telephones Cables Ltd Optical transmission system
US4479499A (en) 1982-01-29 1984-10-30 Alfano Robert R Method and apparatus for detecting the presence of caries in teeth using visible light
US4601036A (en) 1982-09-30 1986-07-15 Honeywell Inc. Rapidly tunable laser
HU187188B (en) 1982-11-25 1985-11-28 Koezponti Elelmiszeripari Device for generating radiation of controllable spectral structure
CH663466A5 (en) 1983-09-12 1987-12-15 Battelle Memorial Institute METHOD AND DEVICE FOR DETERMINING THE POSITION OF AN OBJECT IN RELATION TO A REFERENCE.
US5318024A (en) 1985-03-22 1994-06-07 Massachusetts Institute Of Technology Laser endoscope for spectroscopic imaging
EP0590268B1 (en) 1985-03-22 1998-07-01 Massachusetts Institute Of Technology Fiber Optic Probe System for Spectrally Diagnosing Tissue
US4607622A (en) 1985-04-11 1986-08-26 Charles D. Fritch Fiber optic ocular endoscope
US4631498A (en) 1985-04-26 1986-12-23 Hewlett-Packard Company CW Laser wavemeter/frequency locking technique
US4650327A (en) 1985-10-28 1987-03-17 Oximetrix, Inc. Optical catheter calibrating assembly
US5040889A (en) 1986-05-30 1991-08-20 Pacific Scientific Company Spectrometer with combined visible and ultraviolet sample illumination
CA1290019C (en) 1986-06-20 1991-10-01 Hideo Kuwahara Dual balanced optical signal receiver
US4770492A (en) 1986-10-28 1988-09-13 Spectran Corporation Pressure or strain sensitive optical fiber
US4744656A (en) 1986-12-08 1988-05-17 Spectramed, Inc. Disposable calibration boot for optical-type cardiovascular catheter
US4751706A (en) 1986-12-31 1988-06-14 The United States Of America As Represented By The Secretary Of The Army Laser for providing rapid sequence of different wavelengths
US4834111A (en) 1987-01-12 1989-05-30 The Trustees Of Columbia University In The City Of New York Heterodyne interferometer
GB2209221B (en) 1987-09-01 1991-10-23 Litton Systems Inc Hydrophone demodulator circuit and method
US4909631A (en) 1987-12-18 1990-03-20 Tan Raul Y Method for film thickness and refractive index determination
US4890901A (en) 1987-12-22 1990-01-02 Hughes Aircraft Company Color corrector for embedded prisms
US4892406A (en) 1988-01-11 1990-01-09 United Technologies Corporation Method of and arrangement for measuring vibrations
FR2626367B1 (en) 1988-01-25 1990-05-11 Thomson Csf MULTI-POINT FIBER OPTIC TEMPERATURE SENSOR
FR2626383B1 (en) 1988-01-27 1991-10-25 Commissariat Energie Atomique EXTENDED FIELD SCAN AND DEPTH CONFOCAL OPTICAL MICROSCOPY AND DEVICES FOR CARRYING OUT THE METHOD
US4925302A (en) 1988-04-13 1990-05-15 Hewlett-Packard Company Frequency locking device
US5242437A (en) 1988-06-10 1993-09-07 Trimedyne Laser Systems, Inc. Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium
EP0393165B2 (en) 1988-07-13 2007-07-25 Optiscan Pty Ltd Scanning confocal endoscope
GB8817672D0 (en) 1988-07-25 1988-09-01 Sira Ltd Optical apparatus
US5214538A (en) 1988-07-25 1993-05-25 Keymed (Medical And Industrial Equipment) Limited Optical apparatus
US4868834A (en) 1988-09-14 1989-09-19 The United States Of America As Represented By The Secretary Of The Army System for rapidly tuning a low pressure pulsed laser
DE3833602A1 (en) 1988-10-03 1990-02-15 Krupp Gmbh SPECTROMETER FOR SIMULTANEOUS INTENSITY MEASUREMENT IN DIFFERENT SPECTRAL AREAS
EP0449883B1 (en) 1988-12-21 1996-01-31 Massachusetts Institute Of Technology A method for laser induced fluorescence of tissue
US5046501A (en) 1989-01-18 1991-09-10 Wayne State University Atherosclerotic identification
US5085496A (en) 1989-03-31 1992-02-04 Sharp Kabushiki Kaisha Optical element and optical pickup device comprising it
US5317389A (en) 1989-06-12 1994-05-31 California Institute Of Technology Method and apparatus for white-light dispersed-fringe interferometric measurement of corneal topography
US4965599A (en) 1989-11-13 1990-10-23 Eastman Kodak Company Scanning apparatus for halftone image screen writing
KR930003307B1 (en) 1989-12-14 1993-04-24 주식회사 금성사 Three dimensional projector
DD293205B5 (en) 1990-03-05 1995-06-29 Zeiss Carl Jena Gmbh Optical fiber guide for a medical observation device
US5039193A (en) 1990-04-03 1991-08-13 Focal Technologies Incorporated Fibre optic single mode rotary joint
US5262644A (en) 1990-06-29 1993-11-16 Southwest Research Institute Remote spectroscopy for raman and brillouin scattering
US5197470A (en) 1990-07-16 1993-03-30 Eastman Kodak Company Near infrared diagnostic method and instrument
GB9015793D0 (en) 1990-07-18 1990-09-05 Medical Res Council Confocal scanning optical microscope
US5845639A (en) 1990-08-10 1998-12-08 Board Of Regents Of The University Of Washington Optical imaging methods
US5127730A (en) 1990-08-10 1992-07-07 Regents Of The University Of Minnesota Multi-color laser scanning confocal imaging system
US5305759A (en) 1990-09-26 1994-04-26 Olympus Optical Co., Ltd. Examined body interior information observing apparatus by using photo-pulses controlling gains for depths
US5202745A (en) 1990-11-07 1993-04-13 Hewlett-Packard Company Polarization independent optical coherence-domain reflectometry
JP3035336B2 (en) 1990-11-27 2000-04-24 興和株式会社 Blood flow measurement device
US5228001A (en) 1991-01-23 1993-07-13 Syracuse University Optical random access memory
US6198532B1 (en) 1991-02-22 2001-03-06 Applied Spectral Imaging Ltd. Spectral bio-imaging of the eye
US5293872A (en) 1991-04-03 1994-03-15 Alfano Robert R Method for distinguishing between calcified atherosclerotic tissue and fibrous atherosclerotic tissue or normal cardiovascular tissue using Raman spectroscopy
US6485413B1 (en) 1991-04-29 2002-11-26 The General Hospital Corporation Methods and apparatus for forward-directed optical scanning instruments
US6564087B1 (en) 1991-04-29 2003-05-13 Massachusetts Institute Of Technology Fiber optic needle probes for optical coherence tomography imaging
EP0581871B2 (en) 1991-04-29 2009-08-12 Massachusetts Institute Of Technology Apparatus for optical imaging and measurement
US5465147A (en) 1991-04-29 1995-11-07 Massachusetts Institute Of Technology Method and apparatus for acquiring images using a ccd detector array and no transverse scanner
US5748598A (en) 1995-12-22 1998-05-05 Massachusetts Institute Of Technology Apparatus and methods for reading multilayer storage media using short coherence length sources
US6111645A (en) 1991-04-29 2000-08-29 Massachusetts Institute Of Technology Grating based phase control optical delay line
US6501551B1 (en) 1991-04-29 2002-12-31 Massachusetts Institute Of Technology Fiber optic imaging endoscope interferometer with at least one faraday rotator
US5956355A (en) 1991-04-29 1999-09-21 Massachusetts Institute Of Technology Method and apparatus for performing optical measurements using a rapidly frequency-tuned laser
US6134003A (en) 1991-04-29 2000-10-17 Massachusetts Institute Of Technology Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope
US5441053A (en) 1991-05-03 1995-08-15 University Of Kentucky Research Foundation Apparatus and method for multiple wavelength of tissue
DE4128744C1 (en) 1991-08-29 1993-04-22 Siemens Ag, 8000 Muenchen, De
US5353790A (en) 1992-01-17 1994-10-11 Board Of Regents, The University Of Texas System Method and apparatus for optical measurement of bilirubin in tissue
US5212667A (en) 1992-02-03 1993-05-18 General Electric Company Light imaging in a scattering medium, using ultrasonic probing and speckle image differencing
US5248876A (en) 1992-04-21 1993-09-28 International Business Machines Corporation Tandem linear scanning confocal imaging system with focal volumes at different heights
US5486701A (en) 1992-06-16 1996-01-23 Prometrix Corporation Method and apparatus for measuring reflectance in two wavelength bands to enable determination of thin film thickness
US5716324A (en) 1992-08-25 1998-02-10 Fuji Photo Film Co., Ltd. Endoscope with surface and deep portion imaging systems
US5698397A (en) 1995-06-07 1997-12-16 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US5772597A (en) 1992-09-14 1998-06-30 Sextant Medical Corporation Surgical tool end effector
EP0669820B1 (en) 1992-11-18 1997-04-16 Spectrascience, Inc. Apparatus for diagnostic imaging
US5383467A (en) 1992-11-18 1995-01-24 Spectrascience, Inc. Guidewire catheter and apparatus for diagnostic imaging
US5987346A (en) 1993-02-26 1999-11-16 Benaron; David A. Device and method for classification of tissue
FI93781C (en) 1993-03-18 1995-05-26 Wallac Oy Biospecific multiparametric assay method
DE4309056B4 (en) 1993-03-20 2006-05-24 Häusler, Gerd, Prof. Dr. Method and device for determining the distance and scattering intensity of scattering points
DE4310209C2 (en) 1993-03-29 1996-05-30 Bruker Medizintech Optical stationary imaging in strongly scattering media
US5485079A (en) 1993-03-29 1996-01-16 Matsushita Electric Industrial Co., Ltd. Magneto-optical element and optical magnetic field sensor
DE4314189C1 (en) 1993-04-30 1994-11-03 Bodenseewerk Geraetetech Device for the examination of optical fibres made of glass by means of heterodyne Brillouin spectroscopy
US5454807A (en) 1993-05-14 1995-10-03 Boston Scientific Corporation Medical treatment of deeply seated tissue using optical radiation
DE69418248T2 (en) 1993-06-03 1999-10-14 Hamamatsu Photonics Kk Optical laser scanning system with Axikon
US5803082A (en) 1993-11-09 1998-09-08 Staplevision Inc. Omnispectramammography
US5983125A (en) 1993-12-13 1999-11-09 The Research Foundation Of City College Of New York Method and apparatus for in vivo examination of subcutaneous tissues inside an organ of a body using optical spectroscopy
US5450203A (en) 1993-12-22 1995-09-12 Electroglas, Inc. Method and apparatus for determining an objects position, topography and for imaging
US5411016A (en) 1994-02-22 1995-05-02 Scimed Life Systems, Inc. Intravascular balloon catheter for use in combination with an angioscope
US5590660A (en) 1994-03-28 1997-01-07 Xillix Technologies Corp. Apparatus and method for imaging diseased tissue using integrated autofluorescence
DE4411017C2 (en) 1994-03-30 1995-06-08 Alexander Dr Knuettel Optical stationary spectroscopic imaging in strongly scattering objects through special light focusing and signal detection of light of different wavelengths
TW275570B (en) 1994-05-05 1996-05-11 Boehringer Mannheim Gmbh
US5459325A (en) 1994-07-19 1995-10-17 Molecular Dynamics, Inc. High-speed fluorescence scanner
US6159445A (en) 1994-07-20 2000-12-12 Nycomed Imaging As Light imaging contrast agents
ES2233727T3 (en) 1994-08-18 2005-06-16 Carl Zeiss Meditec Ag SURGICAL DEVICE ASSISTED BY OPTICAL COHERENCE TOMOGRAPHY.
US5491524A (en) 1994-10-05 1996-02-13 Carl Zeiss, Inc. Optical coherence tomography corneal mapping apparatus
US5740808A (en) 1996-10-28 1998-04-21 Ep Technologies, Inc Systems and methods for guilding diagnostic or therapeutic devices in interior tissue regions
US5817144A (en) 1994-10-25 1998-10-06 Latis, Inc. Method for contemporaneous application OF laser energy and localized pharmacologic therapy
US6033721A (en) 1994-10-26 2000-03-07 Revise, Inc. Image-based three-axis positioner for laser direct write microchemical reaction
US5600486A (en) 1995-01-30 1997-02-04 Lockheed Missiles And Space Company, Inc. Color separation microlens
DE19506484C2 (en) 1995-02-24 1999-09-16 Stiftung Fuer Lasertechnologie Method and device for selective non-invasive laser myography (LMG)
RU2100787C1 (en) 1995-03-01 1997-12-27 Геликонов Валентин Михайлович Fibre-optical interferometer and fiber-optical piezoelectric transducer
US5526338A (en) 1995-03-10 1996-06-11 Yeda Research & Development Co. Ltd. Method and apparatus for storage and retrieval with multilayer optical disks
US5697373A (en) 1995-03-14 1997-12-16 Board Of Regents, The University Of Texas System Optical method and apparatus for the diagnosis of cervical precancers using raman and fluorescence spectroscopies
US5735276A (en) 1995-03-21 1998-04-07 Lemelson; Jerome Method and apparatus for scanning and evaluating matter
JP3945820B2 (en) 1995-03-24 2007-07-18 オプティスキャン ピーティーワイ リミテッド Optical fiber confocal image forming apparatus with variable near-confocal control means
US5621830A (en) 1995-06-07 1997-04-15 Smith & Nephew Dyonics Inc. Rotatable fiber optic joint
US5785651A (en) 1995-06-07 1998-07-28 Keravision, Inc. Distance measuring confocal microscope
WO1997001167A1 (en) 1995-06-21 1997-01-09 Massachusetts Institute Of Technology Apparatus and method for accessing data on multilayered optical media
ATA107495A (en) 1995-06-23 1996-06-15 Fercher Adolf Friedrich Dr COHERENCE BIOMETRY AND TOMOGRAPHY WITH DYNAMIC COHERENT FOCUS
AU1130797A (en) 1995-08-24 1997-03-19 Purdue Research Foundation Fluorescence lifetime-based imaging and spectroscopy in tissues and other random media
ATE221338T1 (en) 1995-09-20 2002-08-15 Texas Heart Inst YINDICATION OF THERMAL DISCONTINUITY ON VESSEL WALLS
US6615071B1 (en) 1995-09-20 2003-09-02 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
US6763261B2 (en) 1995-09-20 2004-07-13 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
DE19542955C2 (en) 1995-11-17 1999-02-18 Schwind Gmbh & Co Kg Herbert endoscope
US5719399A (en) 1995-12-18 1998-02-17 The Research Foundation Of City College Of New York Imaging and characterization of tissue based upon the preservation of polarized light transmitted therethrough
US5748318A (en) 1996-01-23 1998-05-05 Brown University Research Foundation Optical stress generator and detector
US5840023A (en) 1996-01-31 1998-11-24 Oraevsky; Alexander A. Optoacoustic imaging for medical diagnosis
US5862273A (en) 1996-02-23 1999-01-19 Kaiser Optical Systems, Inc. Fiber optic probe with integral optical filtering
US5843000A (en) 1996-05-07 1998-12-01 The General Hospital Corporation Optical biopsy forceps and method of diagnosing tissue
ATA84696A (en) 1996-05-14 1998-03-15 Adolf Friedrich Dr Fercher METHOD AND ARRANGEMENTS FOR INCREASING CONTRAST IN OPTICAL COHERENCE TOMOGRAPHY
US6020963A (en) 1996-06-04 2000-02-01 Northeastern University Optical quadrature Interferometer
US5795295A (en) 1996-06-25 1998-08-18 Carl Zeiss, Inc. OCT-assisted surgical microscope with multi-coordinate manipulator
US5842995A (en) 1996-06-28 1998-12-01 Board Of Regents, The Univerisity Of Texas System Spectroscopic probe for in vivo measurement of raman signals
US6245026B1 (en) 1996-07-29 2001-06-12 Farallon Medsystems, Inc. Thermography catheter
US5840075A (en) 1996-08-23 1998-11-24 Eclipse Surgical Technologies, Inc. Dual laser device for transmyocardial revascularization procedures
US6396941B1 (en) 1996-08-23 2002-05-28 Bacus Research Laboratories, Inc. Method and apparatus for internet, intranet, and local viewing of virtual microscope slides
JPH1090603A (en) 1996-09-18 1998-04-10 Olympus Optical Co Ltd Endscopic optical system
EP0928433A1 (en) 1996-09-27 1999-07-14 Vincent Lauer Microscope generating a three-dimensional representation of an object
DE19640495C2 (en) 1996-10-01 1999-12-16 Leica Microsystems Device for confocal surface measurement
US5843052A (en) 1996-10-04 1998-12-01 Benja-Athon; Anuthep Irrigation kit for application of fluids and chemicals for cleansing and sterilizing wounds
US6044288A (en) 1996-11-08 2000-03-28 Imaging Diagnostics Systems, Inc. Apparatus and method for determining the perimeter of the surface of an object being scanned
US5872879A (en) 1996-11-25 1999-02-16 Boston Scientific Corporation Rotatable connecting optical fibers
US5871449A (en) 1996-12-27 1999-02-16 Brown; David Lloyd Device and method for locating inflamed plaque in an artery
US5991697A (en) 1996-12-31 1999-11-23 The Regents Of The University Of California Method and apparatus for optical Doppler tomographic imaging of fluid flow velocity in highly scattering media
US5760901A (en) 1997-01-28 1998-06-02 Zetetic Institute Method and apparatus for confocal interference microscopy with background amplitude reduction and compensation
US5801826A (en) 1997-02-18 1998-09-01 Williams Family Trust B Spectrometric device and method for recognizing atomic and molecular signatures
US6120516A (en) 1997-02-28 2000-09-19 Lumend, Inc. Method for treating vascular occlusion
US5968064A (en) 1997-02-28 1999-10-19 Lumend, Inc. Catheter system for treating a vascular occlusion
US6010449A (en) 1997-02-28 2000-01-04 Lumend, Inc. Intravascular catheter system for treating a vascular occlusion
WO1998040007A1 (en) 1997-03-13 1998-09-17 Biomax Technologies, Inc. Methods and apparatus for detecting the rejection of transplanted tissue
US5994690A (en) 1997-03-17 1999-11-30 Kulkarni; Manish D. Image enhancement in optical coherence tomography using deconvolution
US6117128A (en) 1997-04-30 2000-09-12 Kenton W. Gregory Energy delivery catheter and method for the use thereof
US5887009A (en) 1997-05-22 1999-03-23 Optical Biopsy Technologies, Inc. Confocal optical scanning system employing a fiber laser
US6006128A (en) 1997-06-02 1999-12-21 Izatt; Joseph A. Doppler flow imaging using optical coherence tomography
US6002480A (en) 1997-06-02 1999-12-14 Izatt; Joseph A. Depth-resolved spectroscopic optical coherence tomography
US6208415B1 (en) 1997-06-12 2001-03-27 The Regents Of The University Of California Birefringence imaging in biological tissue using polarization sensitive optical coherent tomography
US5920390A (en) 1997-06-26 1999-07-06 University Of North Carolina Fiberoptic interferometer and associated method for analyzing tissue
US6048349A (en) 1997-07-09 2000-04-11 Intraluminal Therapeutics, Inc. Systems and methods for guiding a medical instrument through a body
US5921926A (en) 1997-07-28 1999-07-13 University Of Central Florida Three dimensional optical imaging colposcopy
US5892583A (en) 1997-08-21 1999-04-06 Li; Ming-Chiang High speed inspection of a sample using superbroad radiation coherent interferometer
US6014214A (en) 1997-08-21 2000-01-11 Li; Ming-Chiang High speed inspection of a sample using coherence processing of scattered superbroad radiation
US6069698A (en) 1997-08-28 2000-05-30 Olympus Optical Co., Ltd. Optical imaging apparatus which radiates a low coherence light beam onto a test object, receives optical information from light scattered by the object, and constructs therefrom a cross-sectional image of the object
US6297018B1 (en) 1998-04-17 2001-10-02 Ljl Biosystems, Inc. Methods and apparatus for detecting nucleic acid polymorphisms
US5920373A (en) 1997-09-24 1999-07-06 Heidelberg Engineering Optische Messysteme Gmbh Method and apparatus for determining optical characteristics of a cornea
US6193676B1 (en) 1997-10-03 2001-02-27 Intraluminal Therapeutics, Inc. Guide wire assembly
US5951482A (en) 1997-10-03 1999-09-14 Intraluminal Therapeutics, Inc. Assemblies and methods for advancing a guide wire through body tissue
US6091984A (en) 1997-10-10 2000-07-18 Massachusetts Institute Of Technology Measuring tissue morphology
US5955737A (en) 1997-10-27 1999-09-21 Systems & Processes Engineering Corporation Chemometric analysis for extraction of individual fluorescence spectrum and lifetimes from a target mixture
US6134010A (en) 1997-11-07 2000-10-17 Lucid, Inc. Imaging system using polarization effects to enhance image quality
US6165170A (en) 1998-01-29 2000-12-26 International Business Machines Corporation Laser dermablator and dermablation
US6134033A (en) 1998-02-26 2000-10-17 Tyco Submarine Systems Ltd. Method and apparatus for improving spectral efficiency in wavelength division multiplexed transmission systems
EP2267507A3 (en) 1998-02-26 2011-08-17 The General Hospital Corporation Confocal microscopy with multi-spectral encoding
US6831781B2 (en) 1998-02-26 2004-12-14 The General Hospital Corporation Confocal microscopy with multi-spectral encoding and system and apparatus for spectroscopically encoded confocal microscopy
US6048742A (en) 1998-02-26 2000-04-11 The United States Of America As Represented By The Secretary Of The Air Force Process for measuring the thickness and composition of thin semiconductor films deposited on semiconductor wafers
US6174291B1 (en) 1998-03-09 2001-01-16 Spectrascience, Inc. Optical biopsy system and methods for tissue diagnosis
US6066102A (en) 1998-03-09 2000-05-23 Spectrascience, Inc. Optical biopsy forceps system and method of diagnosing tissue
US6151522A (en) 1998-03-16 2000-11-21 The Research Foundation Of Cuny Method and system for examining biological materials using low power CW excitation raman spectroscopy
US6384915B1 (en) 1998-03-30 2002-05-07 The Regents Of The University Of California Catheter guided by optical coherence domain reflectometry
DE19814057B4 (en) 1998-03-30 2009-01-02 Carl Zeiss Meditec Ag Arrangement for optical coherence tomography and coherence topography
US6175669B1 (en) 1998-03-30 2001-01-16 The Regents Of The Universtiy Of California Optical coherence domain reflectometry guidewire
US6053613A (en) 1998-05-15 2000-04-25 Carl Zeiss, Inc. Optical coherence tomography with new interferometer
US6549801B1 (en) 1998-06-11 2003-04-15 The Regents Of The University Of California Phase-resolved optical coherence tomography and optical doppler tomography for imaging fluid flow in tissue with fast scanning speed and high velocity sensitivity
AU5101699A (en) 1998-07-15 2000-02-07 Corazon Technologies, Inc. Methods and devices for reducing the mineral content of vascular calcified lesions
US6166373A (en) 1998-07-21 2000-12-26 The Institute For Technology Development Focal plane scanner with reciprocating spatial window
US6201551B1 (en) * 1998-09-30 2001-03-13 Xerox Corporation PDL operator overloading for line width management
US6017214A (en) * 1998-10-05 2000-01-25 Pennsylvania Coke Technology, Inc. Interlocking floor brick for non-recovery coke oven
AU6417599A (en) 1998-10-08 2000-04-26 University Of Kentucky Research Foundation, The Methods and apparatus for (in vivo) identification and characterization of vulnerable atherosclerotic plaques
US6274871B1 (en) 1998-10-22 2001-08-14 Vysis, Inc. Method and system for performing infrared study on a biological sample
US6324419B1 (en) 1998-10-27 2001-11-27 Nejat Guzelsu Apparatus and method for non-invasive measurement of stretch
US6191862B1 (en) 1999-01-20 2001-02-20 Lightlab Imaging, Llc Methods and apparatus for high speed longitudinal scanning in imaging systems
US6272376B1 (en) 1999-01-22 2001-08-07 Cedars-Sinai Medical Center Time-resolved, laser-induced fluorescence for the characterization of organic material
US6445944B1 (en) 1999-02-01 2002-09-03 Scimed Life Systems Medical scanning system and related method of scanning
US6615072B1 (en) 1999-02-04 2003-09-02 Olympus Optical Co., Ltd. Optical imaging device
US6185271B1 (en) 1999-02-16 2001-02-06 Richard Estyn Kinsinger Helical computed tomography with feedback scan control
US6264610B1 (en) 1999-05-05 2001-07-24 The University Of Connecticut Combined ultrasound and near infrared diffused light imaging system
US6353693B1 (en) 1999-05-31 2002-03-05 Sanyo Electric Co., Ltd. Optical communication device and slip ring unit for an electronic component-mounting apparatus
US6208887B1 (en) 1999-06-24 2001-03-27 Richard H. Clarke Catheter-delivered low resolution Raman scattering analyzing system for detecting lesions
US7426409B2 (en) 1999-06-25 2008-09-16 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
GB9915082D0 (en) 1999-06-28 1999-08-25 Univ London Optical fibre probe
US6359692B1 (en) 1999-07-09 2002-03-19 Zygo Corporation Method and system for profiling objects having multiple reflective surfaces using wavelength-tuning phase-shifting interferometry
ES2242622T3 (en) 1999-07-30 2005-11-16 Boston Scientific Limited CONNECTION OF ROTATIONAL AND TRANSLATION PROPULSION FOR CATETER ASSEMBLY.
US6687010B1 (en) 1999-09-09 2004-02-03 Olympus Corporation Rapid depth scanning optical imaging device
US6198956B1 (en) 1999-09-30 2001-03-06 Oti Ophthalmic Technologies Inc. High speed sector scanning apparatus having digital electronic control
US6308092B1 (en) 1999-10-13 2001-10-23 C. R. Bard Inc. Optical fiber tissue localization device
US6393312B1 (en) 1999-10-13 2002-05-21 C. R. Bard, Inc. Connector for coupling an optical fiber tissue localization device to a light source
US6538817B1 (en) 1999-10-25 2003-03-25 Aculight Corporation Method and apparatus for optical coherence tomography with a multispectral laser source
JP2001125009A (en) 1999-10-28 2001-05-11 Asahi Optical Co Ltd Endoscope
EP1232377B1 (en) 1999-11-24 2004-03-31 Haag-Streit Ag Method and device for measuring the optical properties of at least two regions located at a distance from one another in a transparent and/or diffuse object
US6738144B1 (en) 1999-12-17 2004-05-18 University Of Central Florida Non-invasive method and low-coherence apparatus system analysis and process control
US6680780B1 (en) 1999-12-23 2004-01-20 Agere Systems, Inc. Interferometric probe stabilization relative to subject movement
US6445485B1 (en) 2000-01-21 2002-09-03 At&T Corp. Micro-machine polarization-state controller
WO2001054580A1 (en) 2000-01-27 2001-08-02 National Research Council Of Canada Visible-near infrared spectroscopy in burn injury assessment
US6475210B1 (en) 2000-02-11 2002-11-05 Medventure Technology Corp Light treatment of vulnerable atherosclerosis plaque
US6556305B1 (en) 2000-02-17 2003-04-29 Veeco Instruments, Inc. Pulsed source scanning interferometer
US6751490B2 (en) 2000-03-01 2004-06-15 The Board Of Regents Of The University Of Texas System Continuous optoacoustic monitoring of hemoglobin concentration and hematocrit
US6567585B2 (en) 2000-04-04 2003-05-20 Optiscan Pty Ltd Z sharpening for fibre confocal microscopes
US6889075B2 (en) 2000-05-03 2005-05-03 Rocky Mountain Biosystems, Inc. Optical imaging of subsurface anatomical structures and biomolecules
JP4460117B2 (en) 2000-06-29 2010-05-12 独立行政法人理化学研究所 Grism
WO2002014944A1 (en) 2000-08-11 2002-02-21 Crystal Fibre A/S Optical wavelength converter
US7625335B2 (en) 2000-08-25 2009-12-01 3Shape Aps Method and apparatus for three-dimensional optical scanning of interior surfaces
AU2001288320A1 (en) 2000-09-05 2002-03-22 Arroyo Optics, Inc. System and method for fabricating components of precise optical path length
EP1434522B1 (en) 2000-10-30 2010-01-13 The General Hospital Corporation Optical systems for tissue analysis
JP3842101B2 (en) 2000-10-31 2006-11-08 富士写真フイルム株式会社 Endoscope device
US6687036B2 (en) 2000-11-03 2004-02-03 Nuonics, Inc. Multiplexed optical scanner technology
EP1409721A2 (en) 2000-11-13 2004-04-21 Gnothis Holding SA Detection of nucleic acid polymorphisms
US6665075B2 (en) 2000-11-14 2003-12-16 Wm. Marshurice University Interferometric imaging system and method
DE10057539B4 (en) 2000-11-20 2008-06-12 Robert Bosch Gmbh Interferometric measuring device
US6558324B1 (en) 2000-11-22 2003-05-06 Siemens Medical Solutions, Inc., Usa System and method for strain image display
US6856712B2 (en) 2000-11-27 2005-02-15 University Of Washington Micro-fabricated optical waveguide for use in scanning fiber displays and scanned fiber image acquisition
US6687007B1 (en) 2000-12-14 2004-02-03 Kestrel Corporation Common path interferometer for spectral image generation
US6501878B2 (en) 2000-12-14 2002-12-31 Nortel Networks Limited Optical fiber termination
ATE345092T1 (en) 2000-12-28 2006-12-15 Palomar Medical Tech Inc APPARATUS FOR THERAPEUTIC ELECTROMAGNETIC RADIATION THERAPY OF THE SKIN
WO2002054948A1 (en) 2001-01-11 2002-07-18 The Johns Hopkins University Assessment of tooth structure using laser based ultrasonics
US7177491B2 (en) 2001-01-12 2007-02-13 Board Of Regents The University Of Texas System Fiber-based optical low coherence tomography
US6609015B2 (en) * 2001-01-18 2003-08-19 Koninklijke Philips Electronics N.V. Analysis of a composition
WO2002075242A2 (en) 2001-01-22 2002-09-26 Roth Jonathan E Method and apparatus for polarization-sensitive optical coherence tomography
US20020140942A1 (en) 2001-02-17 2002-10-03 Fee Michale Sean Acousto-optic monitoring and imaging in a depth sensitive manner
US6563995B2 (en) 2001-04-02 2003-05-13 Lightwave Electronics Optical wavelength filtering apparatus with depressed-index claddings
US6552796B2 (en) 2001-04-06 2003-04-22 Lightlab Imaging, Llc Apparatus and method for selective data collection and signal to noise ratio enhancement using optical coherence tomography
US20020158211A1 (en) 2001-04-16 2002-10-31 Dakota Technologies, Inc. Multi-dimensional fluorescence apparatus and method for rapid and highly sensitive quantitative analysis of mixtures
DE10118760A1 (en) 2001-04-17 2002-10-31 Med Laserzentrum Luebeck Gmbh Procedure for determining the runtime distribution and arrangement
WO2002088684A1 (en) 2001-04-30 2002-11-07 The General Hospital Corporation Method and apparatus for improving image clarity and sensitivity in optical coherence tomography using dynamic feedback to control focal properties and coherence gating
US6701181B2 (en) 2001-05-31 2004-03-02 Infraredx, Inc. Multi-path optical catheter
US6615062B2 (en) 2001-05-31 2003-09-02 Infraredx, Inc. Referencing optical catheters
DE60219627T2 (en) 2001-06-04 2008-02-07 The General Hospital Corp., Boston IDENTIFICATION AND THERAPY OF SENSITIVE PLAQUE WITH PHOTODYNAMIC COMPOUNDS
US6879851B2 (en) 2001-06-07 2005-04-12 Lightlab Imaging, Llc Fiber optic endoscopic gastrointestinal probe
US6702744B2 (en) 2001-06-20 2004-03-09 Advanced Cardiovascular Systems, Inc. Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
US20040166593A1 (en) 2001-06-22 2004-08-26 Nolte David D. Adaptive interferometric multi-analyte high-speed biosensor
US6685885B2 (en) 2001-06-22 2004-02-03 Purdue Research Foundation Bio-optical compact dist system
DE10137530A1 (en) 2001-08-01 2003-02-13 Presens Prec Sensing Gmbh Arrangement and method for multiple fluorescence measurement
AU2002337666A1 (en) 2001-08-03 2003-02-17 Joseph A. Izatt Aspects of basic oct engine technologies for high speed optical coherence tomography and light source and other improvements in oct
US6980299B1 (en) 2001-10-16 2005-12-27 General Hospital Corporation Systems and methods for imaging a sample
US7006231B2 (en) 2001-10-18 2006-02-28 Scimed Life Systems, Inc. Diffraction grating based interferometric systems and methods
US20030216719A1 (en) 2001-12-12 2003-11-20 Len Debenedictis Method and apparatus for treating skin using patterns of optical energy
US6947787B2 (en) 2001-12-21 2005-09-20 Advanced Cardiovascular Systems, Inc. System and methods for imaging within a body lumen
EP1324051A1 (en) 2001-12-26 2003-07-02 Kevin R. Forrester Motion measuring device
US7355716B2 (en) 2002-01-24 2008-04-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US7116887B2 (en) 2002-03-19 2006-10-03 Nufern Optical fiber
US7113818B2 (en) 2002-04-08 2006-09-26 Oti Ophthalmic Technologies Inc. Apparatus for high resolution imaging of moving organs
US7016048B2 (en) 2002-04-09 2006-03-21 The Regents Of The University Of California Phase-resolved functional optical coherence tomography: simultaneous imaging of the stokes vectors, structure, blood flow velocity, standard deviation and birefringence in biological samples
US20030236443A1 (en) 2002-04-19 2003-12-25 Cespedes Eduardo Ignacio Methods and apparatus for the identification and stabilization of vulnerable plaque
JP4135551B2 (en) 2002-05-07 2008-08-20 松下電工株式会社 Position sensor
US7283247B2 (en) 2002-09-25 2007-10-16 Olympus Corporation Optical probe system
US7734332B2 (en) 2002-10-18 2010-06-08 Ariomedica Ltd. Atherectomy system with imaging guidewire
US6847449B2 (en) 2002-11-27 2005-01-25 The United States Of America As Represented By The Secretary Of The Navy Method and apparatus for reducing speckle in optical coherence tomography images
EP1426799A3 (en) 2002-11-29 2005-05-18 Matsushita Electric Industrial Co., Ltd. Optical demultiplexer, optical multi-/demultiplexer, and optical device
DE10260256B9 (en) 2002-12-20 2007-03-01 Carl Zeiss Interferometer system and measuring / machining tool
JP4148771B2 (en) 2002-12-27 2008-09-10 株式会社トプコン Laser device for medical machine
US7123363B2 (en) 2003-01-03 2006-10-17 Rose-Hulman Institute Of Technology Speckle pattern analysis method and system
CA2514189A1 (en) 2003-01-24 2004-08-12 The General Hospital Corporation System and method for identifying tissue using low-coherence interferometry
US7567349B2 (en) 2003-03-31 2009-07-28 The General Hospital Corporation Speckle reduction in optical coherence tomography by path length encoded angular compounding
JP4135550B2 (en) 2003-04-18 2008-08-20 日立電線株式会社 Semiconductor light emitting device
US7110109B2 (en) 2003-04-18 2006-09-19 Ahura Corporation Raman spectroscopy system and method and specimen holder therefor
US7376455B2 (en) 2003-05-22 2008-05-20 Scimed Life Systems, Inc. Systems and methods for dynamic optical imaging
WO2004111929A2 (en) 2003-05-28 2004-12-23 Duke University Improved system for fourier domain optical coherence tomography
US6943881B2 (en) 2003-06-04 2005-09-13 Tomophase Corporation Measurements of optical inhomogeneity and other properties in substances using propagation modes of light
US7263394B2 (en) 2003-06-04 2007-08-28 Tomophase Corporation Coherence-gated optical glucose monitor
KR20130138867A (en) 2003-06-06 2013-12-19 더 제너럴 하스피탈 코포레이션 Process and apparatus for a wavelength tunning source
US20040260182A1 (en) 2003-06-23 2004-12-23 Zuluaga Andres F. Intraluminal spectroscope with wall contacting probe
US20050083534A1 (en) 2003-08-28 2005-04-21 Riza Nabeel A. Agile high sensitivity optical sensor
US6949072B2 (en) 2003-09-22 2005-09-27 Infraredx, Inc. Devices for vulnerable plaque detection
CN103181754A (en) 2003-10-27 2013-07-03 通用医疗公司 Method and apparatus for performing optical imaging using frequency-domain interferometry
DE10351319B4 (en) 2003-10-31 2005-10-20 Med Laserzentrum Luebeck Gmbh Interferometer for optical coherence tomography
WO2005054780A1 (en) 2003-11-28 2005-06-16 The General Hospital Corporation Method and apparatus for three-dimensional spectrally encoded imaging
US7359062B2 (en) 2003-12-09 2008-04-15 The Regents Of The University Of California High speed spectral domain functional optical coherence tomography and optical doppler tomography for in vivo blood flow dynamics and tissue structure
DE10358735B4 (en) 2003-12-15 2011-04-21 Siemens Ag Catheter device comprising a catheter, in particular an intravascular catheter
EP1722669A4 (en) 2004-02-27 2009-05-27 Optiscan Pty Ltd Optical element
US7190464B2 (en) 2004-05-14 2007-03-13 Medeikon Corporation Low coherence interferometry for detecting and characterizing plaques
US7242480B2 (en) 2004-05-14 2007-07-10 Medeikon Corporation Low coherence interferometry for detecting and characterizing plaques
US7447408B2 (en) 2004-07-02 2008-11-04 The General Hospital Corproation Imaging system and related techniques
KR101269455B1 (en) 2004-09-10 2013-05-30 더 제너럴 하스피탈 코포레이션 System and method for optical coherence imaging
JP4997112B2 (en) 2004-09-29 2012-08-08 ザ ジェネラル ホスピタル コーポレイション Apparatus for transmitting at least one electromagnetic radiation and method of manufacturing the same
WO2006044997A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for localized measurement and imaging of viscosity of tissues
US7417740B2 (en) 2004-11-12 2008-08-26 Medeikon Corporation Single trace multi-channel low coherence interferometric sensor
GB0426609D0 (en) 2004-12-03 2005-01-05 Ic Innovations Ltd Analysis
JP2006162366A (en) 2004-12-06 2006-06-22 Fujinon Corp Optical tomographic imaging system
US7450242B2 (en) 2004-12-10 2008-11-11 Fujifilm Corporation Optical tomography apparatus
US7267494B2 (en) 2005-02-01 2007-09-11 Finisar Corporation Fiber stub for cladding mode coupling reduction
WO2006130797A2 (en) 2005-05-31 2006-12-07 The General Hospital Corporation Spectral encoding heterodyne interferometry techniques for imaging
US7391520B2 (en) 2005-07-01 2008-06-24 Carl Zeiss Meditec, Inc. Fourier domain optical coherence tomography employing a swept multi-wavelength laser and a multi-channel receiver
US7668342B2 (en) 2005-09-09 2010-02-23 Carl Zeiss Meditec, Inc. Method of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
JP6046325B2 (en) 2005-09-29 2016-12-14 ザ ジェネラル ホスピタル コーポレイション Method and apparatus for the observation and analysis of one or more biological samples with progressively increased resolution
GB0601183D0 (en) 2006-01-20 2006-03-01 Perkinelmer Ltd Improvements in and relating to imaging
US20070291277A1 (en) 2006-06-20 2007-12-20 Everett Matthew J Spectral domain optical coherence tomography system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050046837A1 (en) * 2003-09-03 2005-03-03 Fujitsu Limited Spectroscopic apparatus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOSKI K ET AL: "Brillouin imaging" APPLIED PHYSICS LETTERS, AIP, AMERICAN INSTITUTE OF PHYSICS, MELVILLE, NY, vol. 87, no. 6, 1 August 2005 (2005-08-01), pages 61903-061903, XP012077377 ISSN: 0003-6951 *
LIPTAK DAVID ET AL: "On the development of a confocal Rayleigh-Brillouin microscope" REVIEW OF SCIENTIFIC INSTRUMENTS, AIP, MELVILLE, NY, US, vol. 78, no. 1, 31 January 2007 (2007-01-31), pages 16106-16106, XP012103628 ISSN: 0034-6748 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109073459A (en) * 2016-02-12 2018-12-21 通用医疗公司 System for executing spectroscopy
JP2019510212A (en) * 2016-02-12 2019-04-11 ザ ジェネラル ホスピタル コーポレイション System for performing spectroscopy
EP3414535A4 (en) * 2016-02-12 2019-10-23 The General Hospital Corporation A system for performing spectroscopy
US11333551B2 (en) 2016-02-12 2022-05-17 The General Hospital Corporation System for performing spectroscopy
US11143555B2 (en) 2017-01-27 2021-10-12 University Of Maryland, College Park Methods and devices for reducing spectral noise and spectrometry systems employing such devices
WO2019036714A1 (en) 2017-08-18 2019-02-21 The General Hospital Corporation Systems and methods for brillouin spectroscopy and imaging of tissues
EP3668368A4 (en) * 2017-08-18 2021-08-18 The General Hospital Corporation Systems and methods for brillouin spectroscopy and imaging of tissues
US11576571B2 (en) 2017-08-18 2023-02-14 The General Hospital Corporation Systems and methods for Brillouin spectroscopy and imaging of tissues
US11408770B2 (en) 2017-10-30 2022-08-09 University Of Maryland, College Park Brillouin imaging devices, and systems and methods employing such devices

Also Published As

Publication number Publication date
WO2008137637A3 (en) 2009-01-08
US8115919B2 (en) 2012-02-14
US20090323056A1 (en) 2009-12-31

Similar Documents

Publication Publication Date Title
US8115919B2 (en) Methods, arrangements and systems for obtaining information associated with a sample using optical microscopy
US9835840B2 (en) Methods for optical amplified imaging using a two-dimensional spectral brush
US6208886B1 (en) Non-linear optical tomography of turbid media
Scarcelli et al. Confocal Brillouin microscopy for three-dimensional mechanical imaging
CN101918811B (en) Confocal photoacoustic microscopy with optical lateral resolution
US7256894B2 (en) Method and apparatus for performing second harmonic optical coherence tomography
JP5579606B2 (en) Apparatus, system and method for low coherence interferometry (LCI)
EP3838123A1 (en) Methods and arrangements for obtaining information and providing analysis for biological tissues
EP1988825A2 (en) Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
EP1787149A4 (en) Method and apparatus for fiberscope
JP2012198221A (en) System and method for angle decomposition low coherence interference method by endoscope
US10337995B2 (en) Systems and methods for oblique laser scanning
US8797551B2 (en) Compact, affordable optical test, measurement or imaging device
Poon et al. Brillouin imaging for studies of micromechanics in biology and biomedicine: From current state-of-the-art to future clinical translation
Jiang et al. High-resolution second-harmonic optical coherence tomography of collagen in rat-tail tendon
JP2021168927A (en) Optical instrument for biomechanical diagnosis of eye disease
Jongsma et al. Confocal Raman spectroscopy system for noncontact scanning of ocular tissues: an in vitro study
Stachs et al. Spatially resolved Brillouin spectroscopy for in vivo determination of the biomechanical properties of the crystalline lenses
Wenzel et al. Non-Invasive Full Rheological Characterization via Combined Speckle and Brillouin Microscopy
Ren et al. Optical coherence tomography-guided confocal Raman microspectroscopy for rapid measurements in tissues
Dahal et al. Characterization of multiphoton photoacoustic spectroscopy for subsurface brain tissue diagnosis and imaging
Petersen et al. Mid-infrared OCT imaging in highly scattering samples using real-time upconversion of broadband supercontinuum covering from 3.6-4.6 μm
Larson et al. Fundamentals of reflectance confocal microscopy
Antonacci Brillouin scattering microscopy for mechanical imaging
Dadkhah et al. Penta-Modal Imaging Platform with OCT-guided Dynamic Focusing for Simultaneous Multimodal Imaging

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08755001

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08755001

Country of ref document: EP

Kind code of ref document: A2